1
|
Franczak E, Maurer A, Drummond VC, Kugler BA, Wells E, Wenger M, Peelor FF, Crosswhite A, McCoin CS, Koch LG, Britton SL, Miller BF, Thyfault JP. Divergence in aerobic capacity and energy expenditure influence metabolic tissue mitochondrial protein synthesis rates in aged rats. GeroScience 2024; 46:2207-2222. [PMID: 37880490 PMCID: PMC10828174 DOI: 10.1007/s11357-023-00985-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/12/2023] [Accepted: 10/14/2023] [Indexed: 10/27/2023] Open
Abstract
Age-associated declines in aerobic capacity promote the development of various metabolic diseases. In rats selectively bred for high/low intrinsic aerobic capacity, greater aerobic capacity reduces susceptibility to metabolic disease while increasing longevity. However, little remains known how intrinsic aerobic capacity protects against metabolic disease, particularly with aging. Here, we tested the effects of aging and intrinsic aerobic capacity on systemic energy expenditure, metabolic flexibility and mitochondrial protein synthesis rates using 24-month-old low-capacity (LCR) or high-capacity runner (HCR) rats. Rats were fed low-fat diet (LFD) or high-fat diet (HFD) for eight weeks, with energy expenditure (EE) and metabolic flexibility assessed utilizing indirect calorimetry during a 48 h fast/re-feeding metabolic challenge. Deuterium oxide (D2O) labeling was used to assess mitochondrial protein fraction synthesis rates (FSR) over a 7-day period. HCR rats possessed greater EE during the metabolic challenge. Interestingly, HFD induced changes in respiratory exchange ratio (RER) in male and female rats, while HCR female rat RER was largely unaffected by diet. In addition, analysis of protein FSR in skeletal muscle, brain, and liver mitochondria showed tissue-specific adaptations between HCR and LCR rats. While brain and liver protein FSR were altered by aerobic capacity and diet, these effects were less apparent in skeletal muscle. Overall, we provide evidence that greater aerobic capacity promotes elevated EE in an aged state, while also regulating metabolic flexibility in a sex-dependent manner. Modulation of mitochondrial protein FSR by aerobic capacity is tissue-specific with aging, likely due to differential energetic requirements by each tissue.
Collapse
Affiliation(s)
- Edziu Franczak
- Department of Cell Biology and Physiology, Medical Center, The University of Kansas, Kansas City, KS, 66160, USA
- Kansas City Veterans Affairs Medical Center, Kansas City, MO, 64128, USA
| | - Adrianna Maurer
- Department of Cell Biology and Physiology, Medical Center, The University of Kansas, Kansas City, KS, 66160, USA
| | - Vivien Csikos Drummond
- Department of Cell Biology and Physiology, Medical Center, The University of Kansas, Kansas City, KS, 66160, USA
| | - Benjamin A Kugler
- Department of Cell Biology and Physiology, Medical Center, The University of Kansas, Kansas City, KS, 66160, USA
- Kansas Center for Metabolism and Obesity Research, Kansas City, MO, 64128, USA
- KU Diabetes Institute and Department of Internal Medicine-Division of Endocrinology and Metabolism, The University of Kansas Medical Center, 3901 Rainbow Boulevard, Hemenway Life Sciences Innovation Center, Mailstop 3043, Kansas City, KS, 66160, USA
| | - Emily Wells
- Department of Cell Biology and Physiology, Medical Center, The University of Kansas, Kansas City, KS, 66160, USA
| | - Madi Wenger
- Department of Cell Biology and Physiology, Medical Center, The University of Kansas, Kansas City, KS, 66160, USA
- Kansas Center for Metabolism and Obesity Research, Kansas City, MO, 64128, USA
- KU Diabetes Institute and Department of Internal Medicine-Division of Endocrinology and Metabolism, The University of Kansas Medical Center, 3901 Rainbow Boulevard, Hemenway Life Sciences Innovation Center, Mailstop 3043, Kansas City, KS, 66160, USA
| | | | - Abby Crosswhite
- Oklahoma Medical Research Foundation, Oklahoma City, OK, 73104, USA
| | - Colin S McCoin
- Department of Cell Biology and Physiology, Medical Center, The University of Kansas, Kansas City, KS, 66160, USA
- Kansas City Veterans Affairs Medical Center, Kansas City, MO, 64128, USA
- Kansas Center for Metabolism and Obesity Research, Kansas City, MO, 64128, USA
- KU Diabetes Institute and Department of Internal Medicine-Division of Endocrinology and Metabolism, The University of Kansas Medical Center, 3901 Rainbow Boulevard, Hemenway Life Sciences Innovation Center, Mailstop 3043, Kansas City, KS, 66160, USA
| | - Lauren G Koch
- Department of Physiology and Pharmacology, The University of Toledo College of Medicine and Life Sciences, Toledo, OH, 43606, USA
| | - Steven L Britton
- Department of Anesthesiology, University of Michigan, Ann Arbor, MI, 48109, USA
| | - Benjamin F Miller
- KU Diabetes Institute and Department of Internal Medicine-Division of Endocrinology and Metabolism, The University of Kansas Medical Center, 3901 Rainbow Boulevard, Hemenway Life Sciences Innovation Center, Mailstop 3043, Kansas City, KS, 66160, USA
| | - John P Thyfault
- Department of Cell Biology and Physiology, Medical Center, The University of Kansas, Kansas City, KS, 66160, USA.
- Kansas City Veterans Affairs Medical Center, Kansas City, MO, 64128, USA.
- Kansas Center for Metabolism and Obesity Research, Kansas City, MO, 64128, USA.
- KU Diabetes Institute and Department of Internal Medicine-Division of Endocrinology and Metabolism, The University of Kansas Medical Center, 3901 Rainbow Boulevard, Hemenway Life Sciences Innovation Center, Mailstop 3043, Kansas City, KS, 66160, USA.
| |
Collapse
|
2
|
Harvey-Thompson AJ, Geissel M, Crabtree JA, Weis MR, Gomez MR, Fein JR, Lewis WE, Ampleford DJ, Awe TJ, Chandler GA, Galloway BR, Hansen SB, Hanson J, Harding EC, Jennings CA, Kimmel M, Knapp PF, Mangan MA, Maurer A, Paguio RR, Perea L, Peterson KJ, Porter JL, Rambo PK, Robertson GK, Rochau GA, Ruiz DE, Shores JE, Slutz SA, Smith GE, Smith IC, Speas CS, Yager-Elorriaga DA, York A. Demonstration of improved laser preheat with a cryogenically cooled magnetized liner inertial fusion platform. Rev Sci Instrum 2023; 94:2890454. [PMID: 37184347 DOI: 10.1063/5.0142587] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/15/2023] [Accepted: 04/17/2023] [Indexed: 05/16/2023]
Abstract
We report on progress implementing and testing cryogenically cooled platforms for Magnetized Liner Inertial Fusion (MagLIF) experiments. Two cryogenically cooled experimental platforms were developed: an integrated platform fielded on the Z pulsed power generator that combines magnetization, laser preheat, and pulsed-power-driven fuel compression and a laser-only platform in a separate chamber that enables measurements of the laser preheat energy using shadowgraphy measurements. The laser-only experiments suggest that ∼89% ± 10% of the incident energy is coupled to the fuel in cooled targets across the energy range tested, significantly higher than previous warm experiments that achieved at most 67% coupling and in line with simulation predictions. The laser preheat configuration was applied to a cryogenically cooled integrated experiment that used a novel cryostat configuration that cooled the MagLIF liner from both ends. The integrated experiment, z3576, coupled 2.32 ± 0.25 kJ preheat energy to the fuel, the highest to-date, demonstrated excellent temperature control and nominal current delivery, and produced one of the highest pressure stagnations as determined by a Bayesian analysis of the data.
Collapse
Affiliation(s)
- A J Harvey-Thompson
- Sandia National Laboratories, P.O. Box 5800, Albuquerque, New Mexico 87185, USA
| | - M Geissel
- Sandia National Laboratories, P.O. Box 5800, Albuquerque, New Mexico 87185, USA
| | - J A Crabtree
- Sandia National Laboratories, P.O. Box 5800, Albuquerque, New Mexico 87185, USA
| | - M R Weis
- Sandia National Laboratories, P.O. Box 5800, Albuquerque, New Mexico 87185, USA
| | - M R Gomez
- Sandia National Laboratories, P.O. Box 5800, Albuquerque, New Mexico 87185, USA
| | - J R Fein
- Sandia National Laboratories, P.O. Box 5800, Albuquerque, New Mexico 87185, USA
| | - W E Lewis
- Sandia National Laboratories, P.O. Box 5800, Albuquerque, New Mexico 87185, USA
| | - D J Ampleford
- Sandia National Laboratories, P.O. Box 5800, Albuquerque, New Mexico 87185, USA
| | - T J Awe
- Sandia National Laboratories, P.O. Box 5800, Albuquerque, New Mexico 87185, USA
| | - G A Chandler
- Sandia National Laboratories, P.O. Box 5800, Albuquerque, New Mexico 87185, USA
| | - B R Galloway
- Sandia National Laboratories, P.O. Box 5800, Albuquerque, New Mexico 87185, USA
| | - S B Hansen
- Sandia National Laboratories, P.O. Box 5800, Albuquerque, New Mexico 87185, USA
| | - J Hanson
- Sandia National Laboratories, P.O. Box 5800, Albuquerque, New Mexico 87185, USA
| | - E C Harding
- Sandia National Laboratories, P.O. Box 5800, Albuquerque, New Mexico 87185, USA
| | - C A Jennings
- Sandia National Laboratories, P.O. Box 5800, Albuquerque, New Mexico 87185, USA
| | - M Kimmel
- Sandia National Laboratories, P.O. Box 5800, Albuquerque, New Mexico 87185, USA
| | - P F Knapp
- Sandia National Laboratories, P.O. Box 5800, Albuquerque, New Mexico 87185, USA
| | - M A Mangan
- Sandia National Laboratories, P.O. Box 5800, Albuquerque, New Mexico 87185, USA
| | - A Maurer
- Sandia National Laboratories, P.O. Box 5800, Albuquerque, New Mexico 87185, USA
| | - R R Paguio
- General Atomics, San Diego, California 92121, USA
| | - L Perea
- Sandia National Laboratories, P.O. Box 5800, Albuquerque, New Mexico 87185, USA
| | - K J Peterson
- Sandia National Laboratories, P.O. Box 5800, Albuquerque, New Mexico 87185, USA
| | - J L Porter
- Sandia National Laboratories, P.O. Box 5800, Albuquerque, New Mexico 87185, USA
| | - P K Rambo
- Sandia National Laboratories, P.O. Box 5800, Albuquerque, New Mexico 87185, USA
| | - G K Robertson
- Sandia National Laboratories, P.O. Box 5800, Albuquerque, New Mexico 87185, USA
| | - G A Rochau
- Sandia National Laboratories, P.O. Box 5800, Albuquerque, New Mexico 87185, USA
| | - D E Ruiz
- Sandia National Laboratories, P.O. Box 5800, Albuquerque, New Mexico 87185, USA
| | - J E Shores
- Sandia National Laboratories, P.O. Box 5800, Albuquerque, New Mexico 87185, USA
| | - S A Slutz
- Sandia National Laboratories, P.O. Box 5800, Albuquerque, New Mexico 87185, USA
| | - G E Smith
- General Atomics, San Diego, California 92121, USA
| | - I C Smith
- Sandia National Laboratories, P.O. Box 5800, Albuquerque, New Mexico 87185, USA
| | - C S Speas
- Sandia National Laboratories, P.O. Box 5800, Albuquerque, New Mexico 87185, USA
| | - D A Yager-Elorriaga
- Sandia National Laboratories, P.O. Box 5800, Albuquerque, New Mexico 87185, USA
| | - A York
- Sandia National Laboratories, P.O. Box 5800, Albuquerque, New Mexico 87185, USA
| |
Collapse
|
3
|
Stierwalt HD, Morris EM, Maurer A, Apte U, Phillips K, Li T, Meers GME, Koch LG, Britton SL, Graf G, Rector RS, Mercer K, Shankar K, Thyfault JP. Rats with high aerobic capacity display enhanced transcriptional adaptability and upregulation of bile acid metabolism in response to an acute high-fat diet. Physiol Rep 2022; 10:e15405. [PMID: 35923133 PMCID: PMC9350427 DOI: 10.14814/phy2.15405] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/20/2022] [Revised: 07/01/2022] [Accepted: 07/13/2022] [Indexed: 06/09/2023] Open
Abstract
Rats selectively bred for the high intrinsic aerobic capacity runner (HCR) or low aerobic capacity runner (LCR) show pronounced differences in susceptibility for high-fat/high sucrose (HFHS) diet-induced hepatic steatosis and insulin resistance, replicating the protective effect of high aerobic capacity in humans. We have previously shown multiple systemic differences in energy and substrate metabolism that impacts steatosis between HCR and LCR rats. This study aimed to investigate hepatic-specific mechanisms of action via changes in gene transcription. Livers of HCR rats had a greater number of genes that significantly changed in response to 3-day HFHS compared with LCR rats (171 vs. 75 genes: >1.5-fold, p < 0.05). HCR and LCR rats displayed numerous baseline differences in gene expression while on a low-fat control diet (CON). A 3-day HFHS diet resulted in greater expression of genes involved in the conversion of excess acetyl-CoA to cholesterol and bile acid (BA) synthesis compared with the CON diet in HCR, but not LCR rats. These results were associated with higher fecal BA loss and lower serum BA concentrations in HCR rats. Exercise studies in rats and mice also revealed higher hepatic expression of cholesterol and BA synthesis genes. Overall, these results suggest that high aerobic capacity and exercise are associated with upregulated BA synthesis paired with greater fecal excretion of cholesterol and BA, an effect that may play a role in protection against hepatic steatosis in rodents.
Collapse
Affiliation(s)
- Harrison D. Stierwalt
- Molecular and Integrative PhysiologyUniversity of Kansas Medical CenterKansas CityMissouriUSA
- Research ServiceKansas City VA Medical CenterKansas CityMissouriUSA
| | - E. Matthew Morris
- Molecular and Integrative PhysiologyUniversity of Kansas Medical CenterKansas CityMissouriUSA
| | - Adrianna Maurer
- Molecular and Integrative PhysiologyUniversity of Kansas Medical CenterKansas CityMissouriUSA
| | - Udayan Apte
- Department of Pharmacology, Toxicology, and TherapeuticsUniversity of Kansas Medical CenterKansas CityMissouriUSA
| | | | - Tiangang Li
- Department of PhysiologyUniversity of Oklahoma Health Sciences CenterOklahoma CityOklahomaUSA
| | - Grace M. E. Meers
- Division of Gastroenterology and HepatologyUniversity of MissouriColumbiaMissouriUSA
- Division of Nutrition and Exercise PhysiologyColumbiaMissouriUSA
| | - Lauren G. Koch
- Physiology and PharmacologyThe University of ToledoToledoOhioUSA
| | | | - Greg Graf
- Department of Pharmaceutical SciencesSaha Cardiovascular Research Center, University of KentuckyLexingtonKentuckyUSA
| | - R. Scott Rector
- Division of Gastroenterology and HepatologyUniversity of MissouriColumbiaMissouriUSA
- Division of Nutrition and Exercise PhysiologyColumbiaMissouriUSA
- Research ServiceHarry S Truman Memorial VA HospitalColumbiaMissouriUSA
| | - Kelly Mercer
- Arkansas Children's Nutrition CenterUniversity of Arkansas for Medical SciencesLittle RockArkansasUSA
- Department of PediatricsUniversity of Arkansas for Medical SciencesLittle RockArkansasUSA
| | - Kartik Shankar
- Section of Nutrition, Department of PediatricsUniversity of Colorado School of Medicine Anschutz Medical CampusAuroraColoradoUSA
| | - John P. Thyfault
- Molecular and Integrative PhysiologyUniversity of Kansas Medical CenterKansas CityMissouriUSA
- Research ServiceKansas City VA Medical CenterKansas CityMissouriUSA
| |
Collapse
|
4
|
Luu M, Vabres P, Devilliers H, Loffroy R, Phan A, Martin L, Morice-Picard F, Petit F, Willems M, Bessis D, Jacquemont ML, Maruani A, Chiaverini C, Mirault T, Clayton-Smith J, Carpentier M, Fleck C, Maurer A, Yousfi M, Parker VER, Semple RK, Bardou M, Faivre L. Safety and efficacy of low-dose PI3K inhibitor taselisib in adult patients with CLOVES and Klippel-Trenaunay syndrome (KTS): the TOTEM trial, a phase 1/2 multicenter, open-label, single-arm study. Genet Med 2021; 23:2433-2442. [PMID: 34385668 PMCID: PMC8631579 DOI: 10.1038/s41436-021-01290-y] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/05/2021] [Revised: 07/13/2021] [Accepted: 07/13/2021] [Indexed: 11/08/2022] Open
Abstract
PURPOSE PIK3CA pathogenic variants in the PIK3CA-related overgrowth spectrum (PROS) activate phosphoinositide 3-kinase signaling, providing a rationale for targeted therapy, but no drug has proven efficacy and safety in this population. Our aim was to establish the six-month tolerability and efficacy of low-dose taselisib, a selective class I PI3K inhibitor, in PROS patients. METHODS Patients over 16 years with PROS and PIK3CA pathogenic variants were included in a phase IB/IIA multicenter, open-label single-arm trial (six patients at 1 mg/day of taselisib, then 24 at 2 mg/day). The primary outcome was the occurrence of dose limiting toxicity (DLT). Efficacy outcomes were the relative changes after treatment of (1) tissue volume at affected and unaffected sites, both clinically and on imaging; (2) cutaneous vascular outcomes when relevant; (3) biologic parameters; (4) quality of life; and (5) patient-reported outcomes. RESULTS Among 19 enrolled patients, 2 experienced a DLT (enteritis and pachymeningitis) leading to early trial termination (17 treated, 10 completed the study). No serious adverse reaction occurred in the 1 mg cohort (n = 6). No significant reduction in affected tissue volume was observed (mean -4.2%; p = 0.81; SD 14.01). Thirteen (76.4%) participants reported clinical improvement (pain reduction, chronic bleeding resolution, functional improvement). CONCLUSION Despite functional improvement, the safety profile of low-dose taselisib precludes its long-term use.
Collapse
Affiliation(s)
- M Luu
- Centre d'Investigation Clinique-module plurithématique, CHU, Dijon, France.
- INSERM CIC1432, UBFC, Dijon, France.
| | - P Vabres
- Centre référence MAGEC, Dijon, France
- Centre de Référence Anomalies du Développement et Syndromes Malformatifs et FHU TRANSLAD, CHU, Dijon, France
| | - H Devilliers
- INSERM CIC1432, UBFC, Dijon, France
- Centre d'Investigation Clinique-module épidémiologie clinique, CHU, Dijon, France
| | - R Loffroy
- Radiologie Interventionnelle, CHU, Dijon, France
| | - A Phan
- Dermatologie Pédiatrique, HFME, Lyon, France
| | - L Martin
- Centre référence MAGEC, CHU, Angers, France
| | | | - F Petit
- Centre de référence Anomalies du Développement et Syndromes Malformatifs, CHU, Lille, France
| | - M Willems
- Centre de référence Anomalies du Développement et Syndromes Malformatifs, Montpellier, France
| | - D Bessis
- Service de Dermatologie, CHU, Montpellier, France
| | - M L Jacquemont
- Centre de Référence Anomalies du Développement et Syndromes Malformatifs, CHU La Réunion, Saint-Pierre, France
| | - A Maruani
- Centre référence MAGEC, CHU, Tours, France
| | | | - T Mirault
- Centre de référence maladies vasculaires rares, Hôpital européen Georges-Pompidou, AP-HP, Paris, France
- INSERM U970 PARCC, Université de Paris, Paris, France
| | - J Clayton-Smith
- Clinical Genetics and Manchester Centre for Genomic Medicine, NHS and Manchester University, Manchester, UK
| | - M Carpentier
- Délégation à la Recherche Clinique et de l'Innovation, CHU, Dijon, France
| | - C Fleck
- Délégation à la Recherche Clinique et de l'Innovation, CHU, Dijon, France
| | - A Maurer
- Centre d'Investigation Clinique-module plurithématique, CHU, Dijon, France
- INSERM CIC1432, UBFC, Dijon, France
| | - M Yousfi
- Centre de Référence Anomalies du Développement et Syndromes Malformatifs et FHU TRANSLAD, CHU, Dijon, France
| | | | - R K Semple
- Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK
| | - M Bardou
- Centre d'Investigation Clinique-module plurithématique, CHU, Dijon, France
- INSERM CIC1432, UBFC, Dijon, France
| | - L Faivre
- Centre de Référence Anomalies du Développement et Syndromes Malformatifs et FHU TRANSLAD, CHU, Dijon, France
- INSERM UMR1231 GAD, Génétique des Anomalies du Développement, Université Bourgogne Franche-Comté, Dijon, France
| |
Collapse
|
5
|
Mehnaz M, Dracatos P, Pham A, March T, Maurer A, Pillen K, Forrest K, Kulkarni T, Pourkheirandish M, Park RF, Singh D. Discovery and fine mapping of Rph28: a new gene conferring resistance to Puccinia hordei from wild barley. Theor Appl Genet 2021; 134:2167-2179. [PMID: 33774682 DOI: 10.1007/s00122-021-03814-1] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/08/2020] [Accepted: 03/10/2021] [Indexed: 06/12/2023]
Abstract
A new gene Rph28 conferring resistance to barley leaf rust was discovered and fine-mapped on chromosome 5H from wild barley. Leaf rust is a highly destructive disease of barley caused by the fungal pathogen Puccinia hordei. Genetic resistance is considered to be the most effective, economical and eco-friendly approach to minimize losses caused by this disease. A study was undertaken to characterize and fine map a seedling resistance gene identified in a Hordeum vulgare ssp. spontaneum-derived barley line, HEB-04-101, that is broadly effective against a diverse set of Australian P. hordei pathotypes. Genetic analysis of an F3 population derived from a cross between HEB-04-101 and the H. vulgare cultivar Flagship (seedling susceptible) confirmed the presence of a single dominant gene for resistance in HEB-04-101. Selective genotyping was performed on representative plants from non-segregating homozygous resistant and homozygous susceptible F3 families using the targeted genotyping-by-sequencing (tGBS) assay. Putatively linked SNP markers with complete fixation were identified on the long arm of chromosome 5H spanning a physical interval between 622 and 669 Mb based on the 2017 Morex barley reference genome assembly. Several CAPS (cleaved amplified polymorphic sequences) markers were designed from the pseudomolecule sequence of the Morex assembly (v1.0 and v2.0), and 16 polymorphic markers were able to delineate the RphHEB locus to a 0.05 cM genetic interval spanning 98.6 kb. Based on its effectiveness and wild origin, RphHEB is distinct from all other designated Rph genes located on chromosome 5H and therefore the new locus symbol Rph28 is recommended for RphHEB in accordance with the rules and cataloguing system of barley gene nomenclature.
Collapse
Affiliation(s)
- M Mehnaz
- Plant Breeding Institute Cobbitty, School of Life and Environmental Sciences, University of Sydney, Narellan, NSW, Australia
| | - P Dracatos
- Plant Breeding Institute Cobbitty, School of Life and Environmental Sciences, University of Sydney, Narellan, NSW, Australia
| | - A Pham
- School of Agriculture, Food and Wine, University of Adelaide, Waite Campus, Urrbrae, SA, 5064, Australia
| | - T March
- School of Agriculture, Food and Wine, University of Adelaide, Waite Campus, Urrbrae, SA, 5064, Australia
| | - A Maurer
- Martin-Luther-University Halle-Wittenberg, Betty-Heimann-Str. 3, 06120, Halle/Saale, Germany
| | - K Pillen
- Martin-Luther-University Halle-Wittenberg, Betty-Heimann-Str. 3, 06120, Halle/Saale, Germany
| | - K Forrest
- Agriculture Victoria, AgriBio, Centre for AgriBioscience, Bundoora, Victoria, 3083, Australia
| | - T Kulkarni
- Agriculture Victoria, AgriBio, Centre for AgriBioscience, Bundoora, Victoria, 3083, Australia
| | - M Pourkheirandish
- Faculty of Veterinary and Agriculture, The University of Melbourne, Parkville, 3010, Australia
| | - R F Park
- Plant Breeding Institute Cobbitty, School of Life and Environmental Sciences, University of Sydney, Narellan, NSW, Australia
| | - D Singh
- Plant Breeding Institute Cobbitty, School of Life and Environmental Sciences, University of Sydney, Narellan, NSW, Australia.
| |
Collapse
|
6
|
Mercer KE, Maurer A, Pack LM, Ono-Moore K, Spray BJ, Campbell C, Chandler CJ, Burnett D, Souza E, Casazza G, Keim N, Newman J, Hunter G, Fernadez J, Garvey WT, Harper ME, Hoppel C, Adams SH, Thyfault J. Exercise training and diet-induced weight loss increase markers of hepatic bile acid (BA) synthesis and reduce serum total BA concentrations in obese women. Am J Physiol Endocrinol Metab 2021; 320:E864-E873. [PMID: 33645254 PMCID: PMC8238126 DOI: 10.1152/ajpendo.00644.2020] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
Regular exercise has profound metabolic influence on the liver, but effects on bile acid (BA) metabolism are less well known. BAs are synthesized exclusively in the liver from cholesterol via the rate-limiting enzyme cholesterol 7 alpha-hydroxylase (CYP7A1). BAs contribute to the solubilization and absorption of lipids and serve as important signaling molecules, capable of systemic endocrine function. Circulating BAs increase with obesity and insulin resistance, but effects following exercise and diet-induced weight loss are unknown. To test if improvements in fitness and weight loss as a result of exercise training enhance BA metabolism, we measured serum concentrations of total BAs (conjugated and unconjugated primary and secondary BAs) in sedentary, obese, insulin-resistant women (N = 11) before (PRE) and after (POST) a ∼14-wk exercise and diet-induced weight loss intervention. BAs were measured in serum collected after an overnight fast and during an oral glucose tolerance test (OGTT). Serum fibroblast growth factor 19 (FGF19; a regulator of BA synthesis) and 7-alpha-hydroxy-cholesten-3-one (C4, a marker of CYP7A1 enzymatic activity) also were measured. Using linear mixed-model analyses and the change in V̇O2peak (mL/min/kg) as a covariate, we observed that exercise and weight loss intervention decreased total fasting serum BA by ∼30% (P = 0.001) and increased fasting serum C4 concentrations by 55% (P = 0.004). C4 was significantly correlated with serum total BAs only in the POST condition, whereas serum FGF19 was unchanged. These data indicate that a fitness and weight loss intervention modifies BA metabolism in obese women and suggest that improved metabolic health associates with higher postabsorptive (fasting) BA synthesis. Furthermore, pre- vs. postintervention patterns of serum C4 following an OGTT support the hypothesis that responsiveness of BA synthesis to postprandial inhibition is improved after exercise and weight loss.NEW & NOTEWORTHY Exercise and weight loss in previously sedentary, insulin-resistant women facilitates a significant improvement in insulin sensitivity and fitness that may be linked to changes in bile acid metabolism. Diet-induced weight loss plus exercise-induced increases in fitness promote greater postabsorptive bile acid synthesis while also sensitizing the bile acid metabolic system to feedback inhibition during a glucose challenge when glucose and insulin are elevated.
Collapse
Affiliation(s)
- Kelly E Mercer
- Arkansas Children's Nutrition Center, Little Rock, Arkansas
- Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, Arkansas
| | - Adrianna Maurer
- Departments of Molecular and Integrative Physiology and Internal Medicine, Kansas Medical Center, Kansas City, Kansas
| | - Lindsay M Pack
- Arkansas Children's Nutrition Center, Little Rock, Arkansas
| | | | - Beverly J Spray
- Arkansas Children's Research Institute, Little Rock, Arkansas
| | - Caitlin Campbell
- United States Department of Agriculture-Agricultural Research Service Western Human Nutrition Research Center, Davis, California
| | - Carol J Chandler
- United States Department of Agriculture-Agricultural Research Service Western Human Nutrition Research Center, Davis, California
| | - Dustin Burnett
- United States Department of Agriculture-Agricultural Research Service Western Human Nutrition Research Center, Davis, California
| | - Elaine Souza
- United States Department of Agriculture-Agricultural Research Service Western Human Nutrition Research Center, Davis, California
| | - Gretchen Casazza
- Sports Medicine Program, University of California, Davis School of Medicine, Sacramento, California
| | - Nancy Keim
- United States Department of Agriculture-Agricultural Research Service Western Human Nutrition Research Center, Davis, California
| | - John Newman
- United States Department of Agriculture-Agricultural Research Service Western Human Nutrition Research Center, Davis, California
| | - Gary Hunter
- Department of Nutrition Sciences, University of Alabama, Birmingham, Alabama
| | - Jose Fernadez
- Department of Nutrition Sciences, University of Alabama, Birmingham, Alabama
| | - W Timothy Garvey
- Department of Nutrition Sciences, University of Alabama, Birmingham, Alabama
| | - Mary-Ellen Harper
- Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ontario, Canada
| | - Charles Hoppel
- Department of Pharmacology, Case Western Reserve University, Cleveland, Ohio
| | - Sean H Adams
- Department of Surgery, University of California, Davis School of Medicine, Sacramento, California
- Center for Alimentary and Metabolic Science, University of California, Davis School of Medicine, Sacramento, California
| | - John Thyfault
- Departments of Molecular and Integrative Physiology and Internal Medicine, Kansas Medical Center, Kansas City, Kansas
| |
Collapse
|
7
|
Maurer A, Ward JL, Dean K, Billinger SA, Lin H, Mercer KE, Adams SH, Thyfault JP. Divergence in aerobic capacity impacts bile acid metabolism in young women. J Appl Physiol (1985) 2020; 129:768-778. [PMID: 32853107 PMCID: PMC7654689 DOI: 10.1152/japplphysiol.00577.2020] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2020] [Revised: 08/14/2020] [Accepted: 08/25/2020] [Indexed: 02/08/2023] Open
Abstract
Liver adaptations may be critical for regular exercise and high aerobic capacity to protect against metabolic disease, but mechanisms remain unknown. Bile acids (BAs) synthesized in the liver are bioactive and can putatively modify energy metabolism. Regular exercise influences BA metabolism in rodents, but effects in humans are unknown. This study tested whether female subjects screened for high aerobic capacity (Hi-Fit, n = 19) [peak oxygen consumption (V̇o2peak) ≥45 mL·kg-1·min-1] have increased hepatic BA synthesis and different circulating BA composition compared with those matched for age and body mass with low aerobic capacity (Lo-Fit, n = 19) (V̇o2peak ≤35 mL·kg-1·min-1). Diet patterns, activity level, stool, and blood were collected at baseline before participants received a 1-wk standardized, eucaloric diet. After the 1-wk standardized diet, stool and blood were again collected and an oral glucose tolerance test (OGTT) was performed to assess insulin sensitivity and postprandial BA response. Contrary to our hypothesis, serum 7α-hydroxy-4-cholesten-3-one (C4), a surrogate of BA synthesis, was not different between groups, whereas Hi-Fit women had lower fecal BA concentrations compared with Lo-Fit women. However, Lo-Fit women had a higher and more sustained rise in circulating conjugated BAs during the OGTT. Hi-Fit women showed a significant post-OGTT elevation of the secondary BA, lithocholic acid (a potent TGR5 agonist), in contrast to Lo-Fit women where no response was observed. A 1-wk control diet eliminated most differences in circulating BA species between groups. Overall, the results emphasize the importance of using a standardized diet when evaluating BAs and indicate that regular exercise and aerobic capacity modulate BA metabolism under postprandial conditions.NEW & NOTEWORTHY Women with contrasting exercise and aerobic capacity levels show clear differences in bile acid (BA) metabolism. Women with low aerobic capacity (Lo-Fit) have increased circulating conjugated BAs post oral glucose tolerance test (OGTT), whereas women with high aerobic capacity (Hi-Fit) display a transient increase. Hi-Fit women show an increase in the secondary BA, lithocholic acid, during the OGTT not seen in Lo-Fit women. Differences in circulating BA species between Hi- and Lo-Fit women possibly contribute to differences in insulin sensitivity and energy regulation via different signaling mechanisms.
Collapse
Affiliation(s)
- Adrianna Maurer
- Molecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, Kansas
| | - Jaimie L Ward
- Physical Therapy and Rehabilitation Science, University of Kansas Medical Center, Kansas City, Kansas
| | - Kelsey Dean
- Center for Children's Healthy Lifestyles & Nutrition, University of Kansas Medical Center, Kansas City, Kansas
| | - Sandra A Billinger
- Molecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, Kansas
- Physical Therapy and Rehabilitation Science, University of Kansas Medical Center, Kansas City, Kansas
| | - Haixia Lin
- Arkansas Children's Nutrition Center, and University of Arkansas for Medical Sciences, Little Rock, Arkansas
- Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, Arkansas
| | - Kelly E Mercer
- Arkansas Children's Nutrition Center, and University of Arkansas for Medical Sciences, Little Rock, Arkansas
- Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, Arkansas
| | - Sean H Adams
- Arkansas Children's Nutrition Center, and University of Arkansas for Medical Sciences, Little Rock, Arkansas
- Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, Arkansas
| | - John P Thyfault
- Molecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, Kansas
- Center for Children's Healthy Lifestyle and Nutrition, Kansas City, Missouri
- Kansas City Veterans Affairs Medical Center, Kansas City, Missouri
| |
Collapse
|
8
|
Abstract
Background: The COVID-19 pandemic has affected healthcare systems, professionals and patients around the world. At the same time, the burden of cerebrovascular events is considerable. Worldwide, more than one million deaths per year are due to cerebrovascular events, which are the second most frequent cause of death and the main cause of long-term disability in Europe. To approach the challenges of the COVID-19 pandemic and secondary cerebrovascular prevention: Conclusion: We recommend: (1) As in normal times, during the COVID-19 pandemic wave, patients need to seek urgent medical attention in case of any acute cerebrovascular event. This will assure they receive needed rapid cerebrovascular secondary prevention in addition to acute intravenous and endovascular reperfusion strategies. (2) As in normal times, during the COVID-19 pandemic wave, it is of utmost importance that patients adhere to their individual recommendations for secondary prevention. (3) Optimal secondary but also primary cerebrovascular prevention might reduce the burden of COVID-19 now and during potential subsequent waves. (4) Patients with cerebrovascular disease should strictly adhere to advice concerning the pandemic provided by their governments and to pandemic-related recommendations for them as individuals expressed by their treating physicians.
Collapse
Affiliation(s)
- G Padlina
- Department of Neurology, Inselspital, University Hospital and University of Bern, Bern, Switzerland
| | - S Bellwald
- Department of Neurology, Inselspital, University Hospital and University of Bern, Bern, Switzerland
| | - A Maurer
- Department of Neurology, Inselspital, University Hospital and University of Bern, Bern, Switzerland
| | - MR Heldner
- Department of Neurology, Inselspital, University Hospital and University of Bern, Bern, Switzerland
| |
Collapse
|
9
|
Lahmann B, Gatu Johnson M, Hahn KD, Frenje JA, Ampleford DJ, Jones B, Mangan MA, Maurer A, Ruiz CL, Séguin FH, Petrasso RD. A neutron recoil-spectrometer for measuring yield and determining liner areal densities at the Z facility. Rev Sci Instrum 2020; 91:073501. [PMID: 32752812 DOI: 10.1063/5.0011499] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/21/2020] [Accepted: 06/12/2020] [Indexed: 06/11/2023]
Abstract
A proof-of-principle CR-39 based neutron-recoil-spectrometer was built and fielded on the Z facility. Data from this experiment match indium activation yields within a factor of 2 using simplified instrument response function models. The data also demonstrate the need for neutron shielding in order to infer liner areal densities. A new shielded design has been developed. The spectrometer is expected to achieve signal-to-background greater than 2 for the down-scattered neutron signal and greater than 30 for the primary signal.
Collapse
Affiliation(s)
- B Lahmann
- Plasma Science and Fusion Center at Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - M Gatu Johnson
- Plasma Science and Fusion Center at Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - K D Hahn
- Pulsed Power Sciences Center at Sandia National Laboratory, Albuquerque, New Mexico 87123, USA
| | - J A Frenje
- Plasma Science and Fusion Center at Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - D J Ampleford
- Pulsed Power Sciences Center at Sandia National Laboratory, Albuquerque, New Mexico 87123, USA
| | - B Jones
- Pulsed Power Sciences Center at Sandia National Laboratory, Albuquerque, New Mexico 87123, USA
| | - M A Mangan
- Pulsed Power Sciences Center at Sandia National Laboratory, Albuquerque, New Mexico 87123, USA
| | - A Maurer
- Pulsed Power Sciences Center at Sandia National Laboratory, Albuquerque, New Mexico 87123, USA
| | - C L Ruiz
- Pulsed Power Sciences Center at Sandia National Laboratory, Albuquerque, New Mexico 87123, USA
| | - F H Séguin
- Plasma Science and Fusion Center at Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - R D Petrasso
- Plasma Science and Fusion Center at Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| |
Collapse
|
10
|
Luu M, Vabres P, Devilliers H, Loffroy R, Carpentier M, Maurer A, Yousfi M, Fleck C, Phan A, Martin L, Morice-Picard F, Petit F, Willems M, Bessis D, Jacquemont ML, Maruani A, Chiaverini C, Bardou M, Faivre L. Enseignements de l’essai TOTEM évaluant le tasélisib, inhibiteur de la PI3 K, dans les syndromes hypertrophiques liés à PIK3CA. Ann Dermatol Venereol 2019. [DOI: 10.1016/j.annder.2019.09.031] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
11
|
McCoin CS, Von Schulze A, Allen J, Fuller KNZ, Xia Q, Koestler DC, Houchen CJ, Maurer A, Dorn GW, Shankar K, Morris EM, Thyfault JP. Sex modulates hepatic mitochondrial adaptations to high-fat diet and physical activity. Am J Physiol Endocrinol Metab 2019; 317:E298-E311. [PMID: 31039007 PMCID: PMC6732468 DOI: 10.1152/ajpendo.00098.2019] [Citation(s) in RCA: 34] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/11/2019] [Revised: 04/29/2019] [Accepted: 04/29/2019] [Indexed: 02/06/2023]
Abstract
The impact of sexual dimorphism and mitophagy on hepatic mitochondrial adaptations during the treatment of steatosis with physical activity are largely unknown. Here, we tested if deficiencies in liver-specific peroxisome proliferative activated-receptor-γ coactivator-1α (PGC-1α), a transcriptional coactivator of biogenesis, and BCL-2/ADENOVIRUS EIB 19-kDa interacting protein (BNIP3), a mitophagy regulator, would impact hepatic mitochondrial adaptations (respiratory capacity, H2O2 production, mitophagy) to a high-fat diet (HFD) and HFD plus physical activity via voluntary wheel running (VWR) in both sexes. Male and female wild-type (WT), liver-specific PGC-1α heterozygote (LPGC-1α), and BNIP3 null mice were thermoneutral housed (29-31°C) and divided into three groups: sedentary-low-fat diet (LFD), 16 wk of (HFD), or 16 wk of HFD with VWR for the final 8 wk (HFD + VWR) (n = 5-7/sex/group). HFD did not impair mitochondrial respiratory capacity or coupling in any group; however, HFD + VWR significantly increased maximal respiratory capacity only in WT and PGC-1α females. Males required VWR to elicit mitochondrial adaptations that were inherently present in sedentary females including greater mitochondrial coupling control and reduced H2O2 production. Females had overall reduced markers of mitophagy, steatosis, and liver damage. Steatosis and markers of liver injury were present in sedentary male mice on the HFD and were effectively reduced with VWR despite no resolution of steatosis. Overall, reductions in PGC-1α and loss of BNIP3 only modestly impacted mitochondrial adaptations to HFD and HFD + VWR with the biggest effect seen in BNIP3 females. In conclusion, hepatic mitochondrial adaptations to HFD and treatment of HFD-induced steatosis with VWR are more dependent on sex than PGC-1α or BNIP3.
Collapse
Affiliation(s)
- Colin S McCoin
- Department of Molecular and Integrative Physiology, University of Kansas Medical Center , Kansas City, Kansas
- Kansas City Veterans Affairs Medical Center , Kansas City, Kansas
| | - Alex Von Schulze
- Department of Molecular and Integrative Physiology, University of Kansas Medical Center , Kansas City, Kansas
- Kansas City Veterans Affairs Medical Center , Kansas City, Kansas
| | - Julie Allen
- Department of Molecular and Integrative Physiology, University of Kansas Medical Center , Kansas City, Kansas
- Kansas City Veterans Affairs Medical Center , Kansas City, Kansas
| | - Kelly N Z Fuller
- Department of Molecular and Integrative Physiology, University of Kansas Medical Center , Kansas City, Kansas
| | - Qing Xia
- Department of Biostatistics, University of Kansas Medical Center , Kansas City, Kansas
| | - Devin C Koestler
- Department of Biostatistics, University of Kansas Medical Center , Kansas City, Kansas
| | - Claire J Houchen
- Department of Molecular and Integrative Physiology, University of Kansas Medical Center , Kansas City, Kansas
| | - Adrianna Maurer
- Department of Molecular and Integrative Physiology, University of Kansas Medical Center , Kansas City, Kansas
| | - Gerald W Dorn
- Center for Pharmacogenomics, Department of Internal Medicine, Washington University School of Medicine , St. Louis, Missouri
| | - Kartik Shankar
- Arkansas Children's Nutrition Center and the Department of Pediatrics, University of Arkansas for Medical Sciences , Little Rock, Arizona
| | - E Matthew Morris
- Department of Molecular and Integrative Physiology, University of Kansas Medical Center , Kansas City, Kansas
- Kansas City Veterans Affairs Medical Center , Kansas City, Kansas
| | - John P Thyfault
- Department of Molecular and Integrative Physiology, University of Kansas Medical Center , Kansas City, Kansas
- Kansas City Veterans Affairs Medical Center , Kansas City, Kansas
| |
Collapse
|
12
|
Maurer A, Mercer KE, Adams SH, Thyfault J. Associations between Aerobic Capacity, Hepatic Bile Acid Synthesis and Fecal Bile Acid Concentration in Humans. FASEB J 2019. [DOI: 10.1096/fasebj.2019.33.1_supplement.699.10] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
| | - Kelly E. Mercer
- University of Arkansas for Medical SciencesLittle RockAR
- Arkansas Children's Nutrition CenterLittle RockAR
| | - Sean H. Adams
- University of Arkansas for Medical SciencesLittle RockAR
- Arkansas Children's Nutrition CenterLittle RockAR
| | | |
Collapse
|
13
|
Franczak E, Maurer A, Thyfault J. EXERCISE AND SEX IMPACT HEPATIC BILE ACID METABOLISM AND FECAL EXCRETION. FASEB J 2019. [DOI: 10.1096/fasebj.2019.33.1_supplement.lb434] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
| | | | - John Thyfault
- KUMCKansas CityKS
- Kansas City VA Medical CenterKansas CityMO
| |
Collapse
|
14
|
McCoin C, Von Schulze A, Morris EM, Allen J, Fuller KNZ, Maurer A, Thyfault JP. Sex‐Dependent Murine Hepatic Mitochondrial and Mitophagy Responses to High‐Fat Diet and Exercise. FASEB J 2019. [DOI: 10.1096/fasebj.2019.33.1_supplement.699.9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Colin McCoin
- University of Kansas Medical CenterKansas CityKS
- Kansas City VA Medical CenterKansas CityMO
| | - Alex Von Schulze
- University of Kansas Medical CenterKansas CityKS
- Kansas City VA Medical CenterKansas CityMO
| | - E. Matthew Morris
- University of Kansas Medical CenterKansas CityKS
- Kansas City VA Medical CenterKansas CityMO
| | - Julie Allen
- University of Kansas Medical CenterKansas CityKS
- Kansas City VA Medical CenterKansas CityMO
| | | | | | - John P Thyfault
- University of Kansas Medical CenterKansas CityKS
- Kansas City VA Medical CenterKansas CityMO
| |
Collapse
|
15
|
Vogel JK, Pivovaroff MJ, Kozioziemski B, Walton CC, Ayers J, Bell P, Bradley D, Descalle MA, Hau-Riege S, Pickworth LA, Ampleford DJ, Ball CR, Bourdon CJ, Fein JR, Gard PD, Maurer A, Wu M, Ames A, Bruni R, Romaine S, Kilaru K, Roberts OJ, Ramsey B. Design and raytrace simulations of a multilayer-coated Wolter x-ray optic for the Z machine at Sandia National Laboratories. Rev Sci Instrum 2018; 89:10G113. [PMID: 30399826 DOI: 10.1063/1.5038811] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/05/2018] [Accepted: 06/08/2018] [Indexed: 06/08/2023]
Abstract
Recent breakthroughs in the fabrication of small-radii Wolter optics for astrophysics allow high energy density facilities to consider such optics as novel x-ray diagnostics at photon energies of 15-50 keV. Recently, the Lawrence Livermore National Laboratory, Sandia National Laboratories (SNL), the Smithsonian Astrophysical Observatory, and the NASA Marshall Space Flight Center jointly developed and fabricated the first custom Wolter microscope for implementation in SNL's Z machine with optimized sensitivity at 17.5 keV. To achieve spatial resolution of order 100-200 microns over a field of view of 5 × 5 × 5 mm3 with high throughput and narrow energy bandpass, the geometry of the optic and its multilayer required careful design and optimization. While the geometry mainly influences resolution and the field of view of the diagnostic, the mirror coating determines the spectral response and throughput. Here we outline the details of the design and fabrication process for the first multilayer-coated Wolter I optic for SNL's Z machine (Z Wolter), including its W/Si multilayer, and present results of raytrace simulations completed to predict and verify the performance of the optic.
Collapse
Affiliation(s)
- J K Vogel
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
| | - M J Pivovaroff
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
| | - B Kozioziemski
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
| | - C C Walton
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
| | - J Ayers
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
| | - P Bell
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
| | - D Bradley
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
| | - M-A Descalle
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
| | - S Hau-Riege
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
| | - L A Pickworth
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
| | - D J Ampleford
- Sandia National Laboratories, Albuquerque, New Mexico 87123, USA
| | - C R Ball
- Sandia National Laboratories, Albuquerque, New Mexico 87123, USA
| | - C J Bourdon
- Sandia National Laboratories, Albuquerque, New Mexico 87123, USA
| | - J R Fein
- Sandia National Laboratories, Albuquerque, New Mexico 87123, USA
| | - P D Gard
- Sandia National Laboratories, Albuquerque, New Mexico 87123, USA
| | - A Maurer
- Sandia National Laboratories, Albuquerque, New Mexico 87123, USA
| | - M Wu
- Sandia National Laboratories, Albuquerque, New Mexico 87123, USA
| | - A Ames
- Smithsonian Astrophysical Observatory, Cambridge, Massachusetts 02138, USA
| | - R Bruni
- Smithsonian Astrophysical Observatory, Cambridge, Massachusetts 02138, USA
| | - S Romaine
- Smithsonian Astrophysical Observatory, Cambridge, Massachusetts 02138, USA
| | - K Kilaru
- Universities Space Research Association, Huntsville, Alabama 35805, USA
| | - O J Roberts
- Universities Space Research Association, Huntsville, Alabama 35805, USA
| | - B Ramsey
- NASA Marshall Space Flight Center, Huntsville, Alabama 35812, USA
| |
Collapse
|
16
|
Fein JR, Ampleford DJ, Vogel JK, Kozioziemski B, Walton CC, Wu M, Ball CR, Ames A, Ayers J, Bell P, Bourdon CJ, Bradley D, Bruni R, Dunham GS, Gard PD, Johnson D, Kilaru K, Kirtley C, Lake PW, Maurer A, Nielsen-Weber L, Pickworth LA, Pivovaroff MJ, Ramsey B, Roberts OJ, Rochau GA, Romaine S, Sullivan M. A Wolter imager on the Z machine to diagnose warm x-ray sources. Rev Sci Instrum 2018; 89:10G115. [PMID: 30399891 DOI: 10.1063/1.5038347] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/02/2018] [Accepted: 08/08/2018] [Indexed: 06/08/2023]
Abstract
A new Wolter x-ray imager has been developed for the Z machine to study the emission of warm (>15 keV) x-ray sources. A Wolter optic has been adapted from observational astronomy and medical imaging, which uses curved x-ray mirrors to form a 2D image of a source with 5 × 5 × 5 mm3 field-of-view and measured 60-300-μm resolution on-axis. The mirrors consist of a multilayer that create a narrow bandpass around the Mo Kα lines at 17.5 keV. We provide an overview of the instrument design and measured imaging performance. In addition, we present the first data from the instrument of a Mo wire array z-pinch on the Z machine, demonstrating improvements in spatial resolution and a 350-4100× increase in the signal over previous pinhole imaging techniques.
Collapse
Affiliation(s)
- J R Fein
- Sandia National Laboratories, 1515 Eubank Blvd SE, Albuquerque, New Mexico 87123, USA
| | - D J Ampleford
- Sandia National Laboratories, 1515 Eubank Blvd SE, Albuquerque, New Mexico 87123, USA
| | - J K Vogel
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551, USA
| | - B Kozioziemski
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551, USA
| | - C C Walton
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551, USA
| | - M Wu
- Sandia National Laboratories, 1515 Eubank Blvd SE, Albuquerque, New Mexico 87123, USA
| | - C R Ball
- Sandia National Laboratories, 1515 Eubank Blvd SE, Albuquerque, New Mexico 87123, USA
| | - A Ames
- Smithsonian Astrophysical Observatory, 60 Garden Street, Cambridge, Massachusetts 02138, USA
| | - J Ayers
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551, USA
| | - P Bell
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551, USA
| | - C J Bourdon
- Sandia National Laboratories, 1515 Eubank Blvd SE, Albuquerque, New Mexico 87123, USA
| | - D Bradley
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551, USA
| | - R Bruni
- Smithsonian Astrophysical Observatory, 60 Garden Street, Cambridge, Massachusetts 02138, USA
| | - G S Dunham
- Sandia National Laboratories, 1515 Eubank Blvd SE, Albuquerque, New Mexico 87123, USA
| | - P D Gard
- Sandia National Laboratories, 1515 Eubank Blvd SE, Albuquerque, New Mexico 87123, USA
| | - D Johnson
- Sandia National Laboratories, 1515 Eubank Blvd SE, Albuquerque, New Mexico 87123, USA
| | - K Kilaru
- Universities Space Research Association, 320 Sparkman Drive, Huntsville, Alabama 35805, USA
| | - C Kirtley
- Sandia National Laboratories, 1515 Eubank Blvd SE, Albuquerque, New Mexico 87123, USA
| | - P W Lake
- Sandia National Laboratories, 1515 Eubank Blvd SE, Albuquerque, New Mexico 87123, USA
| | - A Maurer
- Sandia National Laboratories, 1515 Eubank Blvd SE, Albuquerque, New Mexico 87123, USA
| | - L Nielsen-Weber
- Sandia National Laboratories, 1515 Eubank Blvd SE, Albuquerque, New Mexico 87123, USA
| | - L A Pickworth
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551, USA
| | - M J Pivovaroff
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551, USA
| | - B Ramsey
- NASA-Marshall Spaceflight Center, Huntsville, Alabama 35811, USA
| | - O J Roberts
- Universities Space Research Association, 320 Sparkman Drive, Huntsville, Alabama 35805, USA
| | - G A Rochau
- Sandia National Laboratories, 1515 Eubank Blvd SE, Albuquerque, New Mexico 87123, USA
| | - S Romaine
- Smithsonian Astrophysical Observatory, 60 Garden Street, Cambridge, Massachusetts 02138, USA
| | - M Sullivan
- Sandia National Laboratories, 1515 Eubank Blvd SE, Albuquerque, New Mexico 87123, USA
| |
Collapse
|
17
|
Abstract
The mucin-like carcinoma-associated antigen (MCA) is a mucin with a molecular weight of 350 - 500 kD. It circulates in the serum and its serum content can be determined with the Cobas Core MCA EIA test. Patients with breast cancer show elevated MCA serum levels. The molecule has a polypeptide backbone consisting of three parts: the C-terminus the N-terminus and the transmembrane sequences. The protein is heavily glucosylated with carbohydrate side chains that contain fucose, galactose and N-acetyl galactosamine. The antibody b-12 recognizes a repetitive epitope on the peptide portion of the MCA molecule. The epithelial mucin, which is coded by a unique gene, was cloned using PCR technology. Peptides corresponding to the N- and C-terminus were expressed in E. coli. Analysis of the purified peptides revealed molecular weights of 12 and 18 kD.
Collapse
Affiliation(s)
- A. Maurer
- Roche Diagnostic Systems, a Division of F. Hoffmann-La Roche Ltd, Basel - Switzerland
| | - J. Burckhardt
- Roche Diagnostic Systems, a Division of F. Hoffmann-La Roche Ltd, Basel - Switzerland
| |
Collapse
|
18
|
Maurer A, Sannemann W, Léon J, Pillen K. Estimating parent-specific QTL effects through cumulating linked identity-by-state SNP effects in multiparental populations. Heredity (Edinb) 2016; 118:477-485. [PMID: 27966535 PMCID: PMC5520528 DOI: 10.1038/hdy.2016.121] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2016] [Revised: 11/14/2016] [Accepted: 11/15/2016] [Indexed: 01/08/2023] Open
Abstract
The emergence of multiparental mapping populations enabled plant geneticists to gain deeper insights into the genetic architecture of major agronomic traits and to map quantitative trait loci (QTLs) controlling the expression of these traits. Although the investigated mapping populations are similar, one open question is whether genotype data should be modelled as identical by state (IBS) or identical by descent (IBD). Whereas IBS simply makes use of raw genotype scores to distinguish alleles, IBD data are derived from parental offspring information. We report on comparing IBS and IBD by applying two multiple regression models on four traits studied in the barley nested association mapping (NAM) population HEB-25. We observed that modelling parent-specific IBD genotypes produced a lower number of significant QTLs with increased prediction abilities compared with modelling IBS genotypes. However, at lower trait heritabilities the IBS model produced higher prediction abilities. We developed a method to estimate multiallelic QTL effects in multiparental populations from simple biallelic IBS data. This method is based on cumulating IBS-derived single-nucleotide polymorphism (SNP) effect estimates in a defined genetic region surrounding a QTL. Comparing the resulting parent-specific QTL effects with those obtained from IBD approaches revealed high accordance that could be confirmed through simulations. The method turned out to be also applicable to a barley multiparent advanced generation inter-cross (MAGIC) population. The 'cumulation method' represents a universal approach to differentiate parent-specific QTL effects in multiparental populations, even if no IBD information is available. In future, the method could further benefit from the availability of much denser SNP maps.
Collapse
Affiliation(s)
- A Maurer
- Institute of Agricultural and Nutritional Sciences, Martin Luther University Halle-Wittenberg, Halle, Germany
| | - W Sannemann
- Institute of Agricultural and Nutritional Sciences, Martin Luther University Halle-Wittenberg, Halle, Germany
| | - J Léon
- Institute for Crop Science and Resource Conservation, University Bonn, Bonn, Germany
| | - K Pillen
- Institute of Agricultural and Nutritional Sciences, Martin Luther University Halle-Wittenberg, Halle, Germany
| |
Collapse
|
19
|
Betz O, Maurer A, Verheyden AN, Schmitt C, Kowalik T, Braun J, Grunwald I, Hartwig A, Neuenfeldt M. First protein and peptide characterization of the tarsal adhesive secretions in the desert locust, Schistocerca gregaria, and the Madagascar hissing cockroach, Gromphadorhina portentosa. Insect Mol Biol 2016; 25:541-9. [PMID: 27126627 DOI: 10.1111/imb.12241] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/14/2023]
Abstract
Peptides and proteins have been largely neglected in the analysis of insect tarsal adhesives. After extraction of the protein fraction of the tarsal secretion of the desert locust, Schistocerca gregaria, and Madagascar hissing cockroach, Gromphadorhina portentosa, we combined Fourier transform infrared spectroscopy (FTIR), sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) and matrix-assisted laser desorption/ionization mass spectrometry (MALDI-TOF MS) analyses for protein mass detection. In both these insects, SDS-PAGE analysis revealed several protein bands ranging from 8-190 kDa in both the tarsal secretion and the tibia control sample. Two (S. gregaria) and one (G. portentosa) protein bands exclusively occurred in the tarsal secretion and can be considered to belong to peptides and proteins specific to this secretion. MALDI-TOF analyses revealed 83 different proteins/peptides of 1-7 kDa in S. gregaria, and 48 of 1-11 kDa in G. portentosa. 59 (S. gregaria) and 27 (G. portentosa) proteins exclusively occurred in the tarsal secretion. In G. portentosa, a characteristic series of signal peaks occurred in the range of c. 10-12 kDa, each peak being approximately 160 Da apart. Such a pattern is indicative of proteins modified by glycosylation. Our approach demonstrates that extensive sampling involving considerable time and manpower to sample the adhesive fluid directly from the tarsi opens up a perspective for extracting peptides and proteins in sufficient quantities. This makes them accessible to the field of proteomics and thus to elucidate their possible function in the adhesive process.
Collapse
Affiliation(s)
- O Betz
- Professur für Evolutionsbiologie der Invertebraten, Universität Tübingen, Institut für Evolution und Ökologie, Tübingen, Germany
| | - A Maurer
- Medizinisch-Naturwissenschaftliches Forschungszentrum, Tübingen, Germany
| | - A N Verheyden
- Professur für Evolutionsbiologie der Invertebraten, Universität Tübingen, Institut für Evolution und Ökologie, Tübingen, Germany
| | - C Schmitt
- Professur für Evolutionsbiologie der Invertebraten, Universität Tübingen, Institut für Evolution und Ökologie, Tübingen, Germany
| | - T Kowalik
- Fraunhofer-Institut für Fertigungstechnik und Angewandte Materialforschung, Bremen, Germany
| | - J Braun
- Professur für Evolutionsbiologie der Invertebraten, Universität Tübingen, Institut für Evolution und Ökologie, Tübingen, Germany
| | - I Grunwald
- Fraunhofer-Institut für Fertigungstechnik und Angewandte Materialforschung, Bremen, Germany
| | - A Hartwig
- Fraunhofer-Institut für Fertigungstechnik und Angewandte Materialforschung, Bremen, Germany
| | - M Neuenfeldt
- Professur für Evolutionsbiologie der Invertebraten, Universität Tübingen, Institut für Evolution und Ökologie, Tübingen, Germany
| |
Collapse
|
20
|
Heinisch G, Huber E, Leitner C, Matuszczak B, Maurer A, Pachler S, Prillinger U. Pyridazino[3,4-b][1,5]Benzodiazepin-5-Ones: Synthesis and Biological Evaluation. ACTA ACUST UNITED AC 2016. [DOI: 10.1177/095632029700800410] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Starting from 3,6-dichloropyridazine-4-carboxylic acid chloride, a series of pyridazino[3,4- b][1,5]benzodiazepin-5-ones bearing various substituents in positions 3, 6, 8 and 11 was prepared via N-alkyl-3-alkylamino-6-chloro- N-(2-chloro-5-nitrophenyl)-pyridazine-4-carboxamides. The latter were smoothly accessible by treatment of N-alkyl-3,6-dichloro-N-(2-fluorophenyl)-pyridazine-4-carboxamides with primary aliphatic amines. The new tricyclic compounds, which are structurally related to nevirapine and congeners were screened as human immunodeficiency virus type 1 reverse transcriptase inhibitors; the influence of the substitution pattern on inhibitory potency is discussed.
Collapse
Affiliation(s)
- G Heinisch
- Institute of Pharmaceutical Chemistry, University of Innsbruck, Innrain 52a, A-6020 Innsbruck, Austria
| | - E Huber
- Institute of Pharmaceutical Chemistry, University of Innsbruck, Innrain 52a, A-6020 Innsbruck, Austria
| | - C Leitner
- Institute of Pharmaceutical Chemistry, University of Innsbruck, Innrain 52a, A-6020 Innsbruck, Austria
| | - B Matuszczak
- Institute of Pharmaceutical Chemistry, University of Innsbruck, Innrain 52a, A-6020 Innsbruck, Austria
| | - A Maurer
- Institute of Pharmaceutical Chemistry, University of Innsbruck, Innrain 52a, A-6020 Innsbruck, Austria
| | - S Pachler
- Institute of Pharmaceutical Chemistry, University of Innsbruck, Innrain 52a, A-6020 Innsbruck, Austria
| | - U Prillinger
- Institute of Pharmaceutical Chemistry, University of Innsbruck, Innrain 52a, A-6020 Innsbruck, Austria
| |
Collapse
|
21
|
Wild J, Schmiedel BJ, Maurer A, Raab S, Prokop L, Stevanović S, Dörfel D, Schneider P, Salih HR. Neutralization of (NK-cell-derived) B-cell activating factor by Belimumab restores sensitivity of chronic lymphoid leukemia cells to direct and Rituximab-induced NK lysis. Leukemia 2015; 29:1676-83. [PMID: 25710310 DOI: 10.1038/leu.2015.50] [Citation(s) in RCA: 32] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/18/2014] [Revised: 02/10/2015] [Accepted: 02/19/2015] [Indexed: 12/22/2022]
Abstract
Natural killer (NK) cells are cytotoxic lymphocytes that substantially contribute to the therapeutic benefit of antitumor antibodies like Rituximab, a crucial component in the treatment of B-cell malignancies. In chronic lymphocytic leukemia (CLL), the ability of NK cells to lyse the malignant cells and to mediate antibody-dependent cellular cytotoxicity upon Fc receptor stimulation is compromised, but the underlying mechanisms are largely unclear. We report here that NK-cells activation-dependently produce the tumor necrosis factor family member 'B-cell activating factor' (BAFF) in soluble form with no detectable surface expression, also in response to Fc receptor triggering by therapeutic CD20-antibodies. BAFF in turn enhanced the metabolic activity of primary CLL cells and impaired direct and Rituximab-induced lysis of CLL cells without affecting NK reactivity per se. The neutralizing BAFF antibody Belimumab, which is approved for treatment of systemic lupus erythematosus, prevented the effects of BAFF on the metabolism of CLL cells and restored their susceptibility to direct and Rituximab-induced NK-cell killing in allogeneic and autologous experimental systems. Our findings unravel the involvement of BAFF in the resistance of CLL cells to NK-cell antitumor immunity and Rituximab treatment and point to a benefit of combinatory approaches employing BAFF-neutralizing drugs in B-cell malignancies.
Collapse
Affiliation(s)
- J Wild
- 1] Department of Hematology and Oncology, Eberhard Karls University, Tuebingen, Germany [2] Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany
| | - B J Schmiedel
- Department of Hematology and Oncology, Eberhard Karls University, Tuebingen, Germany
| | - A Maurer
- Interfaculty Institute of Biochemistry, Eberhard Karls University, Tuebingen, Germany
| | - S Raab
- 1] Department of Hematology and Oncology, Eberhard Karls University, Tuebingen, Germany [2] Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany
| | - L Prokop
- Department of Immunology, Eberhard Karls University, Tuebingen, Germany
| | - S Stevanović
- Department of Immunology, Eberhard Karls University, Tuebingen, Germany
| | - D Dörfel
- 1] Department of Hematology and Oncology, Eberhard Karls University, Tuebingen, Germany [2] Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany
| | - P Schneider
- Department of Biochemistry, University of Lausanne, Epalinges, Switzerland
| | - H R Salih
- 1] Department of Hematology and Oncology, Eberhard Karls University, Tuebingen, Germany [2] Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany
| |
Collapse
|
22
|
Sughrue M, Maurer A, Safavi-Abbasi S, Archer J, Sanclement J. Shifting Paradigm from Binostril to Uninostril Endonasal Endoscopic Management of Pituitary Adenomas. Skull Base Surg 2014. [DOI: 10.1055/s-0034-1384055] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
23
|
Sughrue M, Maurer A, Strickland A, Safavi-Abbasi S, Bonney P. Brainstem Cavernous Malformations Resected Via Miniature Craniotomies: Technique and Approach Selection. Skull Base Surg 2014. [DOI: 10.1055/s-0034-1383919] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
24
|
Sughrue M, Maurer A, Safavi-Abbasi S, Cheema A, Ebeling P. The History of the Development of Management Strategies for Petroclival Meningiomas. Skull Base Surg 2014. [DOI: 10.1055/s-0034-1383949] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
25
|
Sughrue M, Maurer A, Bonney P, Ebeling P, Fung K. Tumor Necrosis-Initiated Complement Activation Stimulates Proliferation of Medulloblastoma Cells. Skull Base Surg 2014. [DOI: 10.1055/s-0034-1384138] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
26
|
Ardjomandi N, Klein C, Kohler K, Maurer A, Kalbacher H, Niederländer J, Reinert S, Alexander D. Indirect coating of RGD peptides using a poly-L-lysine spacer enhances jaw periosteal cell adhesion, proliferation, and differentiation into osteogenic tissue. J Biomed Mater Res A 2012; 100:2034-44. [DOI: 10.1002/jbm.a.34062] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2011] [Revised: 10/12/2011] [Accepted: 11/11/2011] [Indexed: 02/04/2023]
|
27
|
Abstract
Polyglandular autoimmune syndromes (PGA) are a heterogeneous group of diseases in which a genetically caused dysfunction of the immune system leads to a destruction of endocrine glands with subsequent loss of function. In addition non-endocrine autoimmune diseases are also frequently present. Due to different patterns of inheritance and occurrence of disease a differentiation is made between juvenile PGA (also called APECED, autoimmune polyendocrinopathy candidiasis ectodermal dystrophy) with a monogenetic alteration of the AIRE (autoimmune regulator) gene, different ethnic distribution and a typical triad of diseases and the adult form, mainly conditioned by mutations of the HLA (human leukocyte antigens) alleles on chromosome 6. The article will briefly deal with the very rare IPEX (immune dysfunction, polyendocrinopathy, enteropathy, x-linked) syndrome, where the FOXP3 gene on chromosome X is altered. Important for the diagnosis are the clinical appearance and functional tests of the endocrine glands and the testing for antibodies. Additionally for PGA I and IPEX genetic testing is advisable. Currently patient-adjusted hormone replacement therapy is very important and screening of family members is recommended.
Collapse
Affiliation(s)
- A Maurer
- I. Medizinische Klinik und Poliklinik, Universitätsmedizin Mainz, Deutschland
| | | | | |
Collapse
|
28
|
Wiegmann B, Maurer A, Hess C, Haverich A, Fischer S. Combined pulmonary and renal support in one extracorporeal device. Thorac Cardiovasc Surg 2011. [DOI: 10.1055/s-0030-1269015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
29
|
Schaer BA, Maurer A, Sticherling C, Buser PT, Osswald S. Routine echocardiography after radiofrequency ablation: to flog a dead horse? Europace 2008; 11:155-7. [DOI: 10.1093/europace/eun360] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023] Open
|
30
|
Maurer A, Steinbauer M. [Emergency checklist: biceps tendon rupture]. MMW Fortschr Med 2007; 149:49. [PMID: 18161438] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/25/2023]
Affiliation(s)
- A Maurer
- Klinik für Unfallchirurgie, Kliniken Dr. Erler gGmbh, Kontumazgarten 4-18, D-909429 Nürnberg
| | | |
Collapse
|
31
|
Atmaca A, Al-Batran SE, Maurer A, Neumann A, Heinzel T, Hentsch B, Schwarz SE, Hövelmann S, Göttlicher M, Knuth A, Jäger E. Valproic acid (VPA) in patients with refractory advanced cancer: a dose escalating phase I clinical trial. Br J Cancer 2007; 97:177-82. [PMID: 17579623 PMCID: PMC2360302 DOI: 10.1038/sj.bjc.6603851] [Citation(s) in RCA: 141] [Impact Index Per Article: 8.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022] Open
Abstract
Altered histone deacetylase (HDAC) activity has been identified in several types of cancer. This study was designed to determine the safety and maximum tolerated dose (MTD) of valproic acid (VPA) as an HDAC inhibitor in cancer patients. Twenty-six pre-treated patients with progressing solid tumours were enrolled in dose-escalating three-patient cohorts, starting at a dose of VPA 30 mg kg(-1) day(-1). VPA was administered as an 1-h infusion daily for 5 consecutive days in a 21-day cycle. Neurocognitive impairment dominated the toxicity profile, with grade 3 or 4 neurological side effects occurring in 8 out of 26 patients. No grade 3 or 4 haematological toxicity was observed. The MTD of infusional VPA was 60 mg kg(-1) day(-1). Biomonitoring of peripheral blood lymphocytes demonstrated the induction of histone hyperacetylation in the majority of patients and downmodulation of HDAC2. Pharmacokinetic studies showed increased mean and maximum serum VPA concentrations >120 and >250 mg l(-1), respectively, in the 90 and 120 mg kg(-1) cohorts, correlating well with the incidence of dose-limiting toxicity (DLT). Neurotoxicity was the main DLT of infusional VPA, doses up to 60 mg kg(-1) day(-1) for 5 consecutive days are well tolerated and show detectable biological activity. Further investigations are warranted to evaluate the effectivity of VPA alone and in combination with other cytotoxic drugs.
Collapse
Affiliation(s)
- A Atmaca
- II. Medizinische Klinik/Onkologie, Krankenhaus Nordwest, Steinbacher Hohl 2-26, D-60488 Frankfurt am Main, Germany.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
32
|
Atmaca A, Maurer A, Heinzel T, Göttlicher M, Neumann A, Al-Batran SE, Martin E, Bartsch I, Knuth A, Jaeger E. A dose-escalating phase I study with valproic acid (VPA) in patients (pts) with advanced cancer. J Clin Oncol 2004. [DOI: 10.1200/jco.2004.22.90140.3169] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- A. Atmaca
- Krankenhaus Nordwest, Frankfurt, Germany; Georg-Speyer-Haus, Frankfurt, Germany; Institut für Toxikologie und Genetik, Karlsruhe, Germany; Univeritätsspital, Zürich, Switzerland
| | - A. Maurer
- Krankenhaus Nordwest, Frankfurt, Germany; Georg-Speyer-Haus, Frankfurt, Germany; Institut für Toxikologie und Genetik, Karlsruhe, Germany; Univeritätsspital, Zürich, Switzerland
| | - T. Heinzel
- Krankenhaus Nordwest, Frankfurt, Germany; Georg-Speyer-Haus, Frankfurt, Germany; Institut für Toxikologie und Genetik, Karlsruhe, Germany; Univeritätsspital, Zürich, Switzerland
| | - M. Göttlicher
- Krankenhaus Nordwest, Frankfurt, Germany; Georg-Speyer-Haus, Frankfurt, Germany; Institut für Toxikologie und Genetik, Karlsruhe, Germany; Univeritätsspital, Zürich, Switzerland
| | - A. Neumann
- Krankenhaus Nordwest, Frankfurt, Germany; Georg-Speyer-Haus, Frankfurt, Germany; Institut für Toxikologie und Genetik, Karlsruhe, Germany; Univeritätsspital, Zürich, Switzerland
| | - S.-E. Al-Batran
- Krankenhaus Nordwest, Frankfurt, Germany; Georg-Speyer-Haus, Frankfurt, Germany; Institut für Toxikologie und Genetik, Karlsruhe, Germany; Univeritätsspital, Zürich, Switzerland
| | - E. Martin
- Krankenhaus Nordwest, Frankfurt, Germany; Georg-Speyer-Haus, Frankfurt, Germany; Institut für Toxikologie und Genetik, Karlsruhe, Germany; Univeritätsspital, Zürich, Switzerland
| | - I. Bartsch
- Krankenhaus Nordwest, Frankfurt, Germany; Georg-Speyer-Haus, Frankfurt, Germany; Institut für Toxikologie und Genetik, Karlsruhe, Germany; Univeritätsspital, Zürich, Switzerland
| | - A. Knuth
- Krankenhaus Nordwest, Frankfurt, Germany; Georg-Speyer-Haus, Frankfurt, Germany; Institut für Toxikologie und Genetik, Karlsruhe, Germany; Univeritätsspital, Zürich, Switzerland
| | - E. Jaeger
- Krankenhaus Nordwest, Frankfurt, Germany; Georg-Speyer-Haus, Frankfurt, Germany; Institut für Toxikologie und Genetik, Karlsruhe, Germany; Univeritätsspital, Zürich, Switzerland
| |
Collapse
|
33
|
Abstract
OBJECTIVES To analyse the heart rate (HR) response and estimate the ultraendurance threshold-the optimum maintainable exercise intensity of ultraendurance cycling-in ultraendurance elite cyclists competing in the Race across the Alps. METHODS HR monitoring was performed in 10 male elite cyclists during the first Race across the Alps in 2001 (distance: 525 km; cumulative altitude difference: 12 600 m) to investigate the exercise intensity of a cycle ultramarathon and the cardiopulmonary strains involved. Four different exercise intensities were defined as percentages of maximal HR (HR(max)) as follows: recovery HR (HR(re)), <70% of HR(max); moderate aerobic HR (HR(ma)), 70-80%; intense aerobic HR (HR(ia)), 80-90%; and high intensity HR (HR(hi)), >90%. RESULTS All athletes investigated finished the competition. The mean racing time was 27 hours and 25 minutes, and the average speed was 18.6 km/h. The mean HR(max) was 186 beats/min, and the average value of measured HRs (HR(average)) was 126 beats/min resulting in a mean HR(average)/HR(max) ratio of 0.68, which probably corresponds to the ultraendurance threshold. The athletes spent 53% (14 hours 32 minutes) of total race time within HR(re), 25% (6 hours 51 minutes) within HR(ma), 19% (5 hours 13 minutes) within HR(ia), and only 3% (49 minutes) within HR(hi), which shows the exercise intensity to be predominantly moderate (HR(re) + HR(ma) = 78% or 21 hours 23 minutes). The HR response was influenced by the course profile as well as the duration. In all subjects, exercise intensity declined significantly during the race, as indicated by a decrease in HR(average)/HR(max) of 23% from 0.86 at the start to 0.66 at the end. CONCLUSIONS A substantial decrease (10% every 10 hours) in the HR response is a general cardiovascular feature of ultramarathon cycling, suggesting that the ultraendurance threshold lies at about 70% of HR(max) in elite ultramarathon cyclists.
Collapse
Affiliation(s)
- G Neumayr
- Institute of Sports Medicine and Cardiovascular Medicine, University Clinics of Innsbruck, Austria.
| | | | | | | | | |
Collapse
|
34
|
Grez M, Becker S, Saulnier S, Knöss H, Ott MG, Maurer A, Dinauer MC, Hoelzer D, Seger R, Hossle JP. Gene therapy of chronic granulomatous disease. Bone Marrow Transplant 2000; 25 Suppl 2:S99-104. [PMID: 10933200 DOI: 10.1038/sj.bmt.1702365] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Chronic granulomatous disease (CGD) is a primary immunodeficiency disorder which results from absence or malfunction of the respiratory burst oxidase normally expressed in neutrophils and other phagocytic leukocytes. Two-thirds of the patients are males hemizygous for mutations in the X-linked gene coding for gp91-phox. As a therapeutic approach towards the X-linked form of CGD bicistronic retroviral vectors containing the gp91-phox gene and a selectable marker gene were constructed. The ability of these vectors to restore NADPH oxidase activity was tested in a human myeloid leukemic cell line that is defective in superoxide production, as well as in primary CD34+ cells obtained from X-CGD patients. Under optimal conditions 80% of the CD34+ cells derived from bone marrow of one X-CGD patient were transduced. The level of superoxide production, in phagocytes derived from transduced cells was 68.9% of normal levels. Considering that low levels of superoxide generating activity are sufficient for normal host defense, the present experiments provide the basis for the development of a gene replacement therapy for the X-linked form of CGD.
Collapse
Affiliation(s)
- M Grez
- Laboratory for Molecular Virology, Georg-Speyer-Haus, Frankfurt, Germany
| | | | | | | | | | | | | | | | | | | |
Collapse
|
35
|
Donath F, Quispe S, Diefenbach K, Maurer A, Fietze I, Roots I. Critical evaluation of the effect of valerian extract on sleep structure and sleep quality. Pharmacopsychiatry 2000; 33:47-53. [PMID: 10761819 DOI: 10.1055/s-2000-7972] [Citation(s) in RCA: 143] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/16/2022]
Abstract
A carefully designed study assessed the short-term (single dose) and long-term (14 days with multiple dosage) effects of a valerian extract on both objective and subjective sleep parameters. The investigation was performed as a randomised, double-blind, placebo-controlled, cross-over study. Sixteen patients (4 male, 12 female) with previously established psychophysiological insomnia (ICSD-code 1.A.1.), and with a median age of 49 (range: 22 to 55), were included in the study. The main inclusion criteria were reported primary insomnia according to ICSD criteria, which was confirmed by polysomnographic recording, and the absence of acute diseases. During the study, the patients underwent 8 polysomnographic recordings: i.e., 2 recordings (baseline and study night) at each time point at which the short and long-term effects of placebo and valerian were tested. The target variable of the study was sleep efficiency. Other parameters describing objective sleep structure were the usual features of sleep-stage analysis, based on the rules of Rechtschaffen and Kales (1968), and the arousal index (scored according to ASDA criteria, 1992) as a sleep microstructure parameter. Subjective parameters such as sleep quality, morning feeling, daytime performance, subjectively perceived duration of sleep latency, and sleep period time were assessed by means of questionnaires. After a single dose of valerian, no effects on sleep structure and subjective sleep assessment were observed. After multiple-dose treatment, sleep efficiency showed a significant increase for both the placebo and the valerian condition in comparison with baseline polysomnography. We confirmed significant differences between valerian and placebo for parameters describing slow-wave sleep. In comparison with the placebo, slow-wave sleep latency was reduced after administration of valerian (21.3 vs. 13.5 min respectively, p<0.05). The SWS percentage of time in bed (TIB) was increased after long-term valerian treatment, in comparison to baseline (9.8 vs. 8.1% respectively, p<0.05). At the same time point, a tendency for shorter subjective sleep latency, as well as a higher correlation coefficient between subjective and objective sleep latencies, were observed under valerian treatment. Other improvements in sleep structure - such as an increase in REM percentage and a decrease in NREM1 percentage - took place simultaneously under placebo and valerian treatment. A remarkable finding of the study was the extremely low number of adverse events during the valerian treatment periods (3 vs. 18 in the placebo period). In conclusion, treatment with a herbal extract of radix valerianae demonstrated positive effects on sleep structure and sleep perception of insomnia patients, and can therefore be recommended for the treatment of patients with mild psychophysiological insomnia.
Collapse
Affiliation(s)
- F Donath
- Institute of Clinical Pharmacology, Charité University Medical Center, Humboldt University of Berlin, Germany
| | | | | | | | | | | |
Collapse
|
36
|
Johne A, Brockmöller J, Bauer S, Maurer A, Langheinrich M, Roots I. Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum). Clin Pharmacol Ther 1999; 66:338-45. [PMID: 10546917 DOI: 10.1053/cp.1999.v66.a101944] [Citation(s) in RCA: 345] [Impact Index Per Article: 13.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
OBJECTIVE Extracts of St John's wort (Hypericum perforatum) are widely used in the treatment of depression, often as an over-the-counter drug. In contrast to its frequent use, knowledge about the pharmacokinetics of ingredients and drug interactions of St John's wort is poor. We studied the interaction between hypericum extract LI160 and digoxin. METHODS The pharmacokinetics of digoxin were investigated in a single-blind, placebo-controlled parallel study. After the achievement of steady state for digoxin on day 5, healthy volunteers received digoxin (0.25 mg/d) either with placebo (n = 12) or with 900 mg/d LI160 (n = 13) for another 10 days. Digoxin concentration profiles on day 5 were compared with day 6 (single-dose interaction) and day 15 (tenth day of co-medication). RESULTS There was a highly significant combined-day-and-group effect for digoxin area under the plasma concentration-time curve [AUC(0-24); P = .0001], peak concentration in plasma (Cmax; P = .0001), and plasma drug concentration at the end of a dosing interval (P = .0003) by two-way ANOVA. No statistically significant change was observed after the first dose of hypericum extract [AUC(0-24) at day 6 of 18.1+/-2.9 microg x h/L and 17.7+/-3.0 microg x h/L, mean +/- SD for placebo and hypericum group, respectively]. However, 10 days of treatment with hypericum extract resulted in a decrease of digoxin AUC(0-24) by 25% (day 15, 17.2+/-4.0 microg x h/L and 12.9+/-2.3 microg x h/L; P = .0035). Furthermore, comparison with the parallel placebo group after multiple dosing showed a reduction in trough concentrations and Cmax of 33% (P = .0023) and 26% (P = .0095), respectively. The effect became increasingly pronounced until the tenth day of co-medication. CONCLUSION As with grapefruit juice, a food product, physicians should also be aware of potential drug-herb interactions. The interaction of St John's wort extract with digoxin kinetics was time dependent. The mechanism involved may be induction of the P-glycoprotein drug transporter.
Collapse
Affiliation(s)
- A Johne
- Institute of Clinical Pharmacology, University Medical Center Charité, Humboldt University, Berlin, Germany
| | | | | | | | | | | |
Collapse
|
37
|
Abstract
Congenital absence of the fibular sesamoid of the hallux is an extremely rare condition. We could find only one previously reported case in the literature. The authors present a second case of congenital absence of the fibular sesamoid and a review of the literature regarding the clinical significance of this anomaly.
Collapse
Affiliation(s)
- C L Jeng
- Department of Orthopaedic Surgery, Johns Hopkins Hospital, Baltimore, Maryland, USA
| | | | | |
Collapse
|
38
|
|
39
|
Abstract
UNLABELLED One-hundred and seventy-nine offspring of 120 probands with a history of febrile convulsions (FC) were studied to determine the risk of seizures and possible factors influencing this risk. The conditions for this study were especially good since all of the probands had undergone clinical and EEG examinations as well as an assessment of family history of seizures during childhood. Hence, for the first time the seizure status of the probands' parents could be included in the calculation of risk in offspring. In sibs the risk was highest if the mother of the proband had experienced seizures (20% vs 9% in offspring of probands with nonaffected parents). Similarly, offspring of probands with affected mothers had a much higher risk (27%) than offspring of probands with affected fathers (7%). Our findings point to a maternal preponderance in the transmission of FC liability. No relationship was found between the presence of EEG traits of a genetic seizure liability (theta rhythms, spikes and waves, photoparoxysmal response, focal sharp waves) in probands during childhood and the seizure risk in their offspring. The present data provide no basis for forming an hypothesis regarding the possible mode of inheritance of FC. This is not surprising since FC as already shown in the EEG-are not a homogeneous disorder, but are caused by a variety of genetic factors occurring in variable constellations. Possibly, in a subgroup of probands with seizure affected mothers the susceptibility to FC follows a multifactorial polygenic mode of inheritance. CONCLUSION The seizure incidence in offspring of individuals with a history of FC was 10% (only FC in 64% of the affected offspring). Offspring of females with affected parents were at an increased risk. Pathological childhood EEG findings of the probands were not related to an increased risk in offspring.
Collapse
Affiliation(s)
- H Doose
- Epilepsy Centre, Epilepsy Research Unit, Raisdorf, Germany
| | | |
Collapse
|
40
|
Fisher RS, Sher DJ, Donahue D, Knight LC, Maurer A, Urbain JL, Krevsky B. Regional differences in gastric acidity and antacid distribution: is a single pH electrode sufficient? Am J Gastroenterol 1997; 92:263-70. [PMID: 9040203] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
UNLABELLED Accurate measurement of intragastric acidity has both clinical and investigational importance in studying gastric pathophysiology. OBJECTIVES The aims of this study were fourfold: (1) to investigate whether regional differences in intragastric acidity exist; (2) to determine intragastric acidity after a standard antacid was administered in both the fasting and fed states; (3) to monitor gastric emptying of and anatomic distribution of radiolabeled antacid during fasting and postprandial periods; and (4) to determine whether the regional effects of ingested antacid correlated with the anatomic distribution of the antacid. METHODS Eight normal male volunteers were studied after fluoroscopically guided nasogastric placement of a tube assembly containing four pH electrodes, with one electrode in each quartile of the stomach. Simultaneous pH readings were made from the four electrodes while fasting, after administration of fasting antacid (30 ml, 79 mEq buffering capacity), postprandially, and after postprandial antacid ingestion. All subjects repeated the protocol on a separate day, five of them using radiolabeled antacid. Gastric emptying and gastric distribution over time of radiolabeled antacid were determined for comparison to regional intragastric acidity. RESULTS Intragastric acidity varied regionally over time in response to meals and to fasting and postprandial antacid. In the fasting state, intragastric acidity returned to baseline after antacid ingestion in a proximal to distal (cardia to antrum) sequence, while postprandial antacid resulted in a return to baseline acidity in a distal to proximal (antrum to cardia) sequence. Radiolabeled antacid distribution paralleled intragastric pH and hydrogen ion concentration in the fasting state, with 82% of the antacid localizing in the distal half of the stomach within the first minute after antacid ingestion. Postprandially, the greatest initial and most prolonged antacid buffering effect occurred proximally, correlating with the presence of radiolabeled antacid. Postprandial antacid remained in the stomach for a longer time (T1/2 = 93.1 +/- 23.4 min) compared with fasting antacid (T1/2 = 23.6 +/- 11.1 min). CONCLUSIONS Measurement of acidity in the four quartiles of the stomach demonstrated regional variation in response to both food and a standard antacid. A single pH electrode does not detect regional intragastric pH differences.
Collapse
Affiliation(s)
- R S Fisher
- Department of Medicine, Temple University School of Medicine, Philadelphia, Pennsylvania 19140, USA
| | | | | | | | | | | | | |
Collapse
|
41
|
Heinisch G, Huber E, Matuszczak B, Maurer A, Prillinger U. Pyridazines 82. Synthesis of pyridazino [3,4-b][1,5]benzodiazepin-5-ones and their biological evaluation as non-nucleoside HIV reverse transcriptase inhibitors. Arch Pharm (Weinheim) 1997; 330:29-34. [PMID: 9112812 DOI: 10.1002/ardp.19973300108] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
Starting from 3,6-dichloro-N-(2-chloro-5-nitrophenyl)-pyridazine-4-carboxamide (7) a series of 6,11-dialkylated pyridazino- [3,4-b][1,5]benzodiazepin-5-ones with a 3-chloro-8-nitro, 8-amino, 8-acetylamino, or 8-chloro substitution pattern was prepared via N-alkyl-3-alkylamino-6-chloro-N-(2-chloro-5-nitrophenyl) -pyridazine-4-carboxamides. The new compounds were screened as non-nucleoside reverse transcriptase inhibitors. The influence of the substitution pattern in compounds 10-13 on inhibitory potency is discussed.
Collapse
Affiliation(s)
- G Heinisch
- Institute of Pharmaceutical Chemistry, University of Innsbruck, Austria
| | | | | | | | | |
Collapse
|
42
|
Ganser A, Maurer A, Contzen C, Seipelt G, Ottmann OG, Schadeck-Gressel C, Kolbe K, Haas R, Zander C, Reutzel R, Hoelzer D. Improved multilineage response of hematopoiesis in patients with myelodysplastic syndromes to a combination therapy with all-trans-retinoic acid, granulocyte colony-stimulating factor, erythropoietin and alpha-tocopherol. Ann Hematol 1996; 72:237-44. [PMID: 8624378 DOI: 10.1007/s002770050166] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
Abstract
Differentiation induction therapy is being tested in myelodysplastic syndromes to ameliorate maturation defects and to restore normal hematopoietic function. To this end, 17 patients (eight with refractory anemia, two with refractory anemia and ring sideroblasts, and seven with refractory anemia and excess of blast cells) were treated with a combination of all-trans-retinoic acid (ATRA), granulocyte colony-stimulating factor (G-CSF), erythropoietin (EPO), and alpha-tocopherol for durations of 8-16 weeks. Absolute neutrophil counts increased in all patients; platelet counts increased in five patients with discontinuation of transfusion needs in two of four transfusion-dependent patients. Stimulation of erythropoiesis was seen in eight patients with an increase in hemoglobin concentration in three, a discontinuation of transfusion requirements in another three, and a significant increase in reticulocyte counts as the only parameter in two patients. Clinically important multilineage responses with increases of hemoglobin levels or discontinuation of transfusion needs were thus seen in six patients (35.3%) with three patients having a trilineage response. Serum erythropoietin concentrations did not differ significantly between responders and nonresponders, but the erythroid response was accompanied by a rise in the serum transferrin receptor levels. In the bone marrow, the myeloid-to-erythroid ratio and the maturation index of myeloid cells increased during therapy, while the percentage of blast cells did not change. Cytogenetic analysis demonstrated the persistence of the abnormal clones. Prior to therapy, nonresponders had a significantly higher serum TNF level than responders. Serum concentrations of TNF-alpha and soluble TNF-alpha receptor significantly increased during therapy, but mainly in the patients without an erythroid and platelet response. Soluble IL-2 receptor and soluble ICAM-1 concentrations both increased. This pilot study demonstrates that treatment with ATRA/G-CSF/EPO/tocopherol is well tolerated, leading to normalization of neutrophil counts in most, and to improvement of platelets and red blood cells in a significant subgroup of patients.
Collapse
Affiliation(s)
- A Ganser
- Department of Hematology, University of Frankfurt, Germany
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
43
|
Huber PR, Schmid HP, Mattarelli G, Strittmatter B, van Steenbrugge GJ, Maurer A. Serum free prostate specific antigen: isoenzymes in benign hyperplasia and cancer of the prostate. Prostate 1995; 27:212-9. [PMID: 7479388 DOI: 10.1002/pros.2990270406] [Citation(s) in RCA: 51] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Abstract
Prostate specific antigen (PSA) in serum of patients with benign prostatic hyperplasia (BPH) or prostate cancer (P-CA) not bound to alpha-1-antichymotrypsin (ACT) was analyzed by chromatofocusing. The procedure allowed the simultaneous separation of complexed and free PSA and the fractionation of the free PSA fraction into several isoenzymes. The detection of the isoenzymes was strongly dependent on the combination of antibodies introduced in the applied commercially available immunoassays (Cobas Core, Delfia). Isoenzymes in sera of patients with benign prostatic hyperplasia were mainly situated in the pI range of 6.6 to 7.3. Isoenzymes in sera of prostate cancer patients or in PSA from LNCAP cells were mainly situated in the pI range 7.0 to 8.3. Neuraminidase treatment of the sera shifted the isoelectric points of all three sources towards more basic pHs. An irregular glycosylation process in the dysplastic cells of the prostate is suggested to be the cause for the shift of the isoelectric points. The difference of isoenzyme distribution along the pH axis is discussed as a diagnostic tool to differentiate between BPH and P-CA.
Collapse
Affiliation(s)
- P R Huber
- Kantonsspital Basel, F. Hoffmann-La Roche Ltd., Switzerland
| | | | | | | | | | | |
Collapse
|
44
|
Huber PR, Mattarelli G, Strittmatter B, van Steenbrugge GJ, Schmid HP, Maurer A. In vivo and in vitro complex formation of prostate specific antigen with alpha 1-anti-chymotrypsin. Prostate 1995; 27:166-75. [PMID: 7567696 DOI: 10.1002/pros.2990270308] [Citation(s) in RCA: 24] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Abstract
Complex formation of prostate specific antigen (PSA) with its inhibitor alpha 1-anti-chymotrypsin (ACT) in vivo and in vitro was studied. Patients with benign prostatic hyperplasia (BPH) were treated with the computer assisted device "Prostatron." This instrument acts by means of thermal destruction of prostatic tissue. The effect of the treatment was followed by measurement of serum PSA concentrations using commercially available immunoassays from Roche (Cobas Core), Wallac (Delfia) and Abbot (IMx) and Hybritech Tandem. Serum samples were further analyzed by molecular sieving on S.300 (Pharmacia) and analyzed for PSA by immuno assay. The complex formation of PSA with ACT in serum was studied, demonstrating this process to be influenced by external stimulus. Patient sera revealing initially normal PSA levels (3 to 5 ng/ml) were stimulated to very high levels of PSA (> or = 140 ng/ml) by Prostatron treatment. The absolute PSA level depends on the assay system and not only on the staging of the prostate tumor. In addition, complex formation was studied in athymic nude mice and in vitro revealing the possible pathways of PSA release. PSA from LNCAP cells kept in vitro show predominantly uncomplexed (free) PSA, whereas PSA from LNCAP cells injected into nude mice appears in the serum of the animals in complexed form. This demonstrates how in the immunization process free and complexed PSA serve as antigens in the standard procedure for the production of antisera for PSA. This model system also can be used for studies of the release mechanism of PSA into blood circulation.
Collapse
Affiliation(s)
- P R Huber
- Hormone Laboratory DZL, Kantonsspital Basel, Roche Diagnostic Systems, F. Hoffmann-La Roche Ltd., Switzerland
| | | | | | | | | | | |
Collapse
|
45
|
Cascorbi I, Drakoulis N, Brockmöller J, Maurer A, Sperling K, Roots I. Arylamine N-acetyltransferase (NAT2) mutations and their allelic linkage in unrelated Caucasian individuals: correlation with phenotypic activity. Am J Hum Genet 1995; 57:581-92. [PMID: 7668286 PMCID: PMC1801274] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023] Open
Abstract
The polymorphic arylamine N-acetyltransferase (NAT2; EC 2.3.1.5) is supposed to be a susceptibility factor for several drug side effects and certain malignancies. A group of 844 unrelated German subjects was genotyped for their acetylation type, and 563 of them were also phenotyped. Seven mutations of the NAT2 gene were evaluated by allele-specific PCR (mutation 341C to T) and PCR-RFLP for mutations at nt positions 191, 282, 481, 590, 803, and 857. From the mutation pattern eight different alleles, including the wild type coding for rapid acetylation and seven alleles coding for slow phenotype, were determined. Four hundred ninety-seven subjects had a genotype of slow acetylation (58.9%; 95% confidence limits 55.5%-62.2%). Phenotypic acetylation capacity was expressed as the ratio of 5-acetylamino-6-formylamino-3-methyluracil and 1-methylxanthine in urine after caffeine intake. Some 6.7% of the cases deviated in genotype and phenotype, but sequencing DNA of these probands revealed no new mutations. Furthermore, linkage pattern of the mutations was always confirmed, as tested in 533 subjects. In vivo acetylation capacity of homozygous wild-type subjects (NAT2*4/*4) was significantly higher than in heterozygous genotypes (P = .001). All mutant alleles showed low in vivo acetylation capacities, including the previously not-yet-defined alleles *5A, *5C, and *13. Moreover, distinct slow genotypes differed significantly among each other, as reflected in lower acetylation capacity of *6A, *7B, and *13 alleles than the group of *5 alleles. The study demonstrated differential phenotypic activity of various NAT2 genes and gives a solid basis for clinical and molecular-epidemiological investigations.
Collapse
Affiliation(s)
- I Cascorbi
- Institute of Clinical Pharmacology, University Clinic Charité, Humboldt University of Berlin, Germany
| | | | | | | | | | | |
Collapse
|
46
|
Geissler RG, Muth J, Maurer A, Mentzel U, Mag M, Engels JW, Hoelzer D, Ganser A. Modified antisense oligodeoxynucleotides against the splice acceptor site of tat do not inhibit in vitro hematopoietic colony growth in HIV-positive patients. Ann Hematol 1995; 71:89-95. [PMID: 7544629 DOI: 10.1007/bf01699252] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Abstract
The hematopoietic failure in the majority of patients with progressive HIV infection is further aggravated by virustatic agents like azidothymidine. As an alternative therapeutic attempt, three derivatives of an antisense oligodeoxynucleotide (ODN) against the splice acceptor site of the tat gene have been shown to inhibit HIV replication in vitro. This study was aimed at examining whether these agents are toxic to the hematopoietic progenitor cells. To this end, bone marrow cells from HIV-positive and healthy persons were depleted from adherent cells to eliminate fibroblasts. In further experiments, the cells were additionally enriched for CD34-positive hematopoietic progenitor cells or were depleted from delta TCS-1-positive T lymphocytes. At concentrations of 1.25-10 microM, the three antisense ODN did not inhibit any erythrocyte or granulocyte-monocyte colony growth from CD34-positive cells, either from the HIV-positive or from the HIV-negative cohort. In contrast to azidothymidine, which served as inhibitory control, a significant increase of colony growth was seen after depletion of fibroblasts, of delta TCS-1-positive cells, or without cell separation. In conclusion, the three oligodeoxynucleotides do not exert any hematotoxic effect but do increase colony formation from low-density bone marrow cells in vitro and could therefore be useful in future clinical studies.
Collapse
Affiliation(s)
- R G Geissler
- Department of Hematology, University of Frankfurt/Main, Germany
| | | | | | | | | | | | | | | |
Collapse
|
47
|
Seipelt G, Ganser A, Duranceyk H, Maurer A, Ottmann OG, Hoelzer D. Induction of soluble IL-2 receptor in patients with myelodysplastic syndromes undergoing high-dose interleukin-3 treatment. Ann Hematol 1994; 68:167-70. [PMID: 8003557 DOI: 10.1007/bf01834361] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Abstract
Sera of ten healthy controls and of 15 patients with myelodysplastic syndromes (MDS) were investigated for soluble interleukin-2 receptor (sIL-2R) with a cell-free enzyme-linked immunosorbent assay (ELISA). The patients with MDS underwent treatment with IL-3: eight patients at dose levels of 250 and 500 micrograms/m2 s.c. daily for 15 days, and seven patients at the dose levels of 60 and 125 micrograms/m2 s.c. three times per week for 12 weeks. None of the patients had reported infectious episodes or been under treatment with cytotoxic drugs and/or cytokines within the preceding 2 months. sIL-2R levels were elevated in MDS patients compared with healthy controls (p < 0.001). sIL-2R increased in the high-dose treatment group from 504 +/- 68 U/ml to 731 +/- 199 U/ml (p < 0.025). The increased sIL-2R expression in MDS could be a primary event due to involvement of lymphocytes in the malignant clone or due to a secondary alteration of the cytokine network caused by chronic neutropenia. A down-regulation of the immune response caused by neutralization of free IL-2 by sIL-2R during IL-3 therapy seems possible.
Collapse
Affiliation(s)
- G Seipelt
- Abteilung für Hämatologie, Johann Wolfgang Goethe-Universität, Frankfurt, Germany
| | | | | | | | | | | |
Collapse
|
48
|
Ganser A, Seipelt G, Verbeek W, Ottmann OG, Maurer A, Kolbe K, Hess U, Elsner S, Reutzel R, Wörmann B. Effect of combination therapy with all-trans-retinoic acid and recombinant human granulocyte colony-stimulating factor in patients with myelodysplastic syndromes. Leukemia 1994; 8:369-75. [PMID: 7510354] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Abstract
Since all-trans retinoic acid (ATRA) and granulocyte colony-stimulating factor (G-CSF) not only enhance proliferation and differentiation of normal myeloid cells but also synergistically promote the differentiation of myeloid leukemic blast cells in vitro, we have started a pilot study of combined treatment with ATRA and G-CSF in patients with myelodysplastic syndrome, to analyze the effect of these drugs on hematopoietic differentiation. ATRA was given at 45 mg/m2/day p.o. from week 1-12 and G-CSF at 5 micrograms/kg/day s.c. from week 5-12 with dose modifications according to the absolute neutrophil counts (ANC). A total of 15 patients, predominantly with refractory anemia, were treated. During initial ATRA therapy, a bilineage response with increases of both ANC and platelet counts occurred in three patients. During combined ATRA/G-CSF therapy, ANC increased in all patients, and platelets increased in three out of 14 evaluable patients. An increase in hemoglobin concentration and a decrease in transfusion requirements occurred in one patient each. In the bone marrow, the myeloid-to-erythroid ratio increased during ATRA treatment and remained increased during concomitant G-CSF administration, while the maturation index of myeloid cells increased only in response to ATRA therapy, but returned to baseline during ATRA/G-CSF treatment. Cytogenetic analysis demonstrated persistence of the abnormal clones in all patients. The number of circulating progenitor cells CFU-GM increased in all patients studied. Serum concentrations of the soluble TNF receptor and IL-2 receptor both increased, while TNF-alpha--already elevated prior to therapy--and soluble ICAM-1 concentrations did not significantly change. Adverse effects included dermatitis and cheilosis in most patients, and a drop in platelet counts related to G-CSF in one patient. The pilot study demonstrates that the combination treatment with ATRA/G-CSF is well tolerated, leading to normalization of ANC in most, and improvement of platelets and red blood cells in a subgroup of patients.
Collapse
Affiliation(s)
- A Ganser
- Department of Hematology, University of Frankfurt, Germany
| | | | | | | | | | | | | | | | | | | |
Collapse
|
49
|
Seipelt G, Ganser A, Duranceyk H, Maurer A, Ottmann OG, Hoelzer D. Induction of TNF-alpha in patients with myelodysplastic syndromes undergoing treatment with interleukin-3. Br J Haematol 1993; 84:749-51. [PMID: 8217838 DOI: 10.1111/j.1365-2141.1993.tb03157.x] [Citation(s) in RCA: 22] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]
Abstract
The study was undertaken to analyse whether the presence or the induction of TNF-alpha, a potent inhibitor of haemopoiesis, might affect the clinical response to treatment with interleukin-3 in patients with myelodysplastic syndromes. A total of 15 patients were treated with IL-3. Baseline serum TNF-alpha levels were elevated in MDS patients (14.2 +/- 2.4 pg/ml) compared to healthy controls (9.1 +/- 1.1 pg/ml). During IL-3 therapy TNF-alpha levels remained unchanged in 3/14 patients in whom platelet counts increased, while in non-responders TNF-alpha levels increased 1.9-fold (P < 0.025). These findings indicate that TNF-alpha not only is induced during IL-3 therapy in MDS patients but that this elevation might be associated with a poor platelet response to therapy.
Collapse
Affiliation(s)
- G Seipelt
- Department of Haematology, Johann Wolfgang Goethe University, Frankfurt am Main, Germany
| | | | | | | | | | | |
Collapse
|
50
|
Ganser A, Ottmann OG, Seipelt G, Lindemann A, Hess U, Geissler G, Maurer A, Frisch J, Schulz G, Mertelsmann R. Effect of long-term treatment with recombinant human interleukin-3 in patients with myelodysplastic syndromes. Leukemia 1993; 7:696-701. [PMID: 8483321] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
Abstract
In a phase II study, involving nine patients with refractory anemia or refractory anemia with ring sideroblasts, the effects of treatment with recombinant human interleukin-3 (IL-3) on hematopoietic function were assessed. Doses of IL-3 ranging from 60 micrograms/m2 during weeks 1-6 to 125 micrograms/m2 during weeks 7-12 were administered as subcutaneous bolus injections three times per week for 12 weeks. Platelet counts increased in six patients. Platelet increase correlated with stable or decreased serum tumour necrosis factor alpha (TNF-alpha) levels, while an increase of TNF-alpha levels during IL-3 therapy occurred in patients with no change or a decrease of platelet counts. Leukocyte counts increased in two patients and reticulocytes in three, without an effect on hemoglobin levels. Morphological analysis of the bone marrow revealed an expansion of the myeloid compartment in seven of eight evaluable patients, mainly due to stimulation of the precursor cells. No improvement of the in vitro growth of hematopoietic progenitor cells was observed. Sequential cytogenetic analyses indicate that IL-3 treatment does not act preferentially on either the cytogenetically abnormal or the normal clones. These results suggest that long-term treatment with low-dose IL-3 stimulates megakaryopoiesis with increase of platelet counts, but that additional later-acting cytokines probably will be required to augment neutrophil and erythrocyte counts.
Collapse
Affiliation(s)
- A Ganser
- Department of Hematology, University of Frankfurt, Germany
| | | | | | | | | | | | | | | | | | | |
Collapse
|